Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Black Diamond Therapeutics expects cash to fund operations into 2023 » 07:48
05/07/21
05/07
07:48
05/07/21
07:48
BDTX

Black Diamond Therapeutics

$25.59 /

+0.83 (+3.35%)

Black Diamond ended the…

Black Diamond ended the first quarter of 2021 with $290.1 million in cash, cash equivalents, and investments compared to $357.2 million as of March 31, 2020. Net cash used in operations was $24.5 million for the first quarter of 2021 compared to $11.3 million for the first quarter of 2020.

ShowHide Related Items >><<
BDTX Black Diamond Therapeutics
$25.59 /

+0.83 (+3.35%)

BDTX Black Diamond Therapeutics
$25.59 /

+0.83 (+3.35%)

03/29/21 Wedbush
Black Diamond Therapeutics added to Best Ideas List at Wedbush
01/07/21 Wedbush
Wedbush bullish on Black Diamond Therapeutics, initiates with an Outperform
01/06/21 Wedbush
Black Diamond Therapeutics initiated with an Outperform at Wedbush
11/24/20 Berenberg
Black Diamond Therapeutics initiated with a Buy at Berenberg
BDTX Black Diamond Therapeutics
$25.59 /

+0.83 (+3.35%)

BDTX Black Diamond Therapeutics
$25.59 /

+0.83 (+3.35%)

Earnings
Black Diamond Therapeutics reports Q1 EPS (84c), consensus (68c) » 07:47
05/07/21
05/07
07:47
05/07/21
07:47
BDTX

Black Diamond Therapeutics

$25.59 /

+0.83 (+3.35%)

"The first quarter…

"The first quarter of 2021 has been marked by meaningful progress across Black Diamond's pipeline of MasterKey inhibitor therapies, each of which is designed by leveraging our proprietary MAP platform to address an unmet need for patients with a range of genetically defined cancers," said David M. Epstein, Ph.D., President and Chief Executive Officer of Black Diamond Therapeutics. "We look forward to presenting initial clinical data for our lead program, BDTX-189, at the ASCO Annual Meeting later this quarter, as well as to continuing to report on progress across the pipeline throughout the year."

ShowHide Related Items >><<
BDTX Black Diamond Therapeutics
$25.59 /

+0.83 (+3.35%)

BDTX Black Diamond Therapeutics
$25.59 /

+0.83 (+3.35%)

03/29/21 Wedbush
Black Diamond Therapeutics added to Best Ideas List at Wedbush
01/07/21 Wedbush
Wedbush bullish on Black Diamond Therapeutics, initiates with an Outperform
01/06/21 Wedbush
Black Diamond Therapeutics initiated with an Outperform at Wedbush
11/24/20 Berenberg
Black Diamond Therapeutics initiated with a Buy at Berenberg
BDTX Black Diamond Therapeutics
$25.59 /

+0.83 (+3.35%)

BDTX Black Diamond Therapeutics
$25.59 /

+0.83 (+3.35%)

Conference/Events
American Association for Cancer Research to hold a virtual meeting » 04:55
04/15/21
04/15
04:55
04/15/21
04:55
MDGEF

MediGene

$4.80 /

+ (+0.00%)

, GLSI

Greenwich LifeSciences

$35.13 /

-0.92 (-2.55%)

, JNCE

Jounce Therapeutics

$9.74 /

+0.485 (+5.24%)

, ATNM

Actinium Pharmaceuticals

$7.80 /

+0.23 (+3.04%)

, BDTX

Black Diamond Therapeutics

$24.70 /

-0.7199 (-2.83%)

, CRSP

Crispr Therapeutics

$123.29 /

+2.34 (+1.93%)

, HARP

Harpoon Therapeutics

$20.61 /

+0.73 (+3.67%)

, ITOS

iTeos Therapeutics

$24.03 /

-1.24 (-4.91%)

, REPL

Replimune Group

$30.50 /

+0.32 (+1.06%)

, RVMD

Revolution Medicines

$39.79 /

+2.18 (+5.80%)

, ZNTL

Zentalis

$47.04 /

+1.43 (+3.14%)

, IMCR

Immunocore

$39.50 /

+6.8 (+20.80%)

, PMVP

PMV Pharmaceuticals

$32.90 /

+0.06 (+0.18%)

, ARVN

Arvinas

$62.89 /

+1.62 (+2.64%)

, IOVA

Iovance Biotherapeutics

$30.00 /

-0.17 (-0.56%)

, ADXS

Advaxis

/

+

, AGEN

Agenus

$2.70 /

-0.015 (-0.55%)

, BPTH

Bio-Path

$6.21 /

-0.41 (-6.19%)

, INCY

Incyte

$82.13 /

+1.5 (+1.86%)

, IMAB

I-MAB

$55.17 /

+5.42 (+10.89%)

, MRSN

Mersana Therapeutics

$17.06 /

+0.89 (+5.50%)

, RUBY

Rubius Therapeutics

$23.77 /

+1.27 (+5.64%)

, PPBT

Purple Biotech

$4.04 /

+ (+0.00%)

, SONN

Sonnet BioTherapeutics

$2.11 /

-0.02 (-0.94%)

, STTK

Shattuck Labs

$32.98 /

+0.56 (+1.73%)

, SURF

Surface Oncology

$7.35 /

+0.095 (+1.31%)

, BGNE

BeiGene

$300.84 /

+0.84 (+0.28%)

, CMPI

Checkmate Pharmaceuticals

$7.44 /

+0.3 (+4.20%)

, BNGO

Bionano Genomics

$6.42 /

-0.47 (-6.82%)

AACR Virtual Annual…

AACR Virtual Annual Meeting 2021 will be held on April 9-15. Webcast Link

ShowHide Related Items >><<
ZNTL Zentalis
$47.04 /

+1.43 (+3.14%)

SURF Surface Oncology
$7.35 /

+0.095 (+1.31%)

STTK Shattuck Labs
$32.98 /

+0.56 (+1.73%)

SONN Sonnet BioTherapeutics
$2.11 /

-0.02 (-0.94%)

RVMD Revolution Medicines
$39.79 /

+2.18 (+5.80%)

RUBY Rubius Therapeutics
$23.77 /

+1.27 (+5.64%)

REPL Replimune Group
$30.50 /

+0.32 (+1.06%)

PPBT Purple Biotech
$4.04 /

+ (+0.00%)

PMVP PMV Pharmaceuticals
$32.90 /

+0.06 (+0.18%)

MRSN Mersana Therapeutics
$17.06 /

+0.89 (+5.50%)

JNCE Jounce Therapeutics
$9.74 /

+0.485 (+5.24%)

ITOS iTeos Therapeutics
$24.03 /

-1.24 (-4.91%)

IOVA Iovance Biotherapeutics
$30.00 /

-0.17 (-0.56%)

INCY Incyte
$82.13 /

+1.5 (+1.86%)

IMCR Immunocore
$39.50 /

+6.8 (+20.80%)

IMAB I-MAB
$55.17 /

+5.42 (+10.89%)

HARP Harpoon Therapeutics
$20.61 /

+0.73 (+3.67%)

GLSI Greenwich LifeSciences
$35.13 /

-0.92 (-2.55%)

CRSP Crispr Therapeutics
$123.29 /

+2.34 (+1.93%)

CMPI Checkmate Pharmaceuticals
$7.44 /

+0.3 (+4.20%)

BPTH Bio-Path
$6.21 /

-0.41 (-6.19%)

BNGO Bionano Genomics
$6.42 /

-0.47 (-6.82%)

BGNE BeiGene
$300.84 /

+0.84 (+0.28%)

BDTX Black Diamond Therapeutics
$24.70 /

-0.7199 (-2.83%)

ATNM Actinium Pharmaceuticals
$7.80 /

+0.23 (+3.04%)

ARVN Arvinas
$62.89 /

+1.62 (+2.64%)

AGEN Agenus
$2.70 /

-0.015 (-0.55%)

ADXS Advaxis
/

+

MDGEF MediGene
$4.80 /

+ (+0.00%)

GLSI Greenwich LifeSciences
$35.13 /

-0.92 (-2.55%)

JNCE Jounce Therapeutics
$9.74 /

+0.485 (+5.24%)

04/12/21 Roth Capital
Jounce reported 'very robust' JTX-8064 analysis, says Roth Capital
03/14/21 Piper Sandler
Jounce Therapeutics initiated with an Overweight at Piper Sandler
02/26/21 H.C. Wainwright
Jounce Therapeutics price target raised to $15 from $11 at H.C. Wainwright
12/04/20 H.C. Wainwright
Jounce Therapeutics assumed with a Buy at H.C. Wainwright
ATNM Actinium Pharmaceuticals
$7.80 /

+0.23 (+3.04%)

04/06/21 William Blair
Actinium's Q4 net loss roughly in line with projected loss, says William Blair
12/29/20 H.C. Wainwright
H.C. Wainwright keeps Buy on Actinium amid 'headline disappointment'
12/29/20 JonesTrading
Actinium selloff today 'clear buying opportunity,' says JonesTrading
11/05/20
Fly Intel: Top five analyst initiations
BDTX Black Diamond Therapeutics
$24.70 /

-0.7199 (-2.83%)

03/29/21 Wedbush
Black Diamond Therapeutics added to Best Ideas List at Wedbush
01/07/21 Wedbush
Wedbush bullish on Black Diamond Therapeutics, initiates with an Outperform
01/06/21 Wedbush
Black Diamond Therapeutics initiated with an Outperform at Wedbush
11/24/20 Berenberg
Black Diamond Therapeutics initiated with a Buy at Berenberg
CRSP Crispr Therapeutics
$123.29 /

+2.34 (+1.93%)

03/17/21 Guggenheim
Editas Medicine assumed with a Neutral at Guggenheim
03/04/21 JMP Securities
Crispr Therapeutics initiated with an Outperform at JMP Securities
03/01/21 Barclays
Crispr Therapeutics price target raised to $140 from $113 at Barclays
02/17/21 Goldman Sachs
Crispr Therapeutics price target lowered to $189 from $193 at Goldman Sachs
HARP Harpoon Therapeutics
$20.61 /

+0.73 (+3.67%)

03/11/21 Roth Capital
Harpoon's 2020/2021 should be 'festival of data,' says Roth Capital
01/04/21 Roth Capital
Harpoon having fourth candidate in clinic 'impressive,' says Roth Capital
12/23/20 H.C. Wainwright
Harpoon Therapeutics assumed with a Buy at H.C. Wainwright
12/16/20 Wedbush
Replimune Group, Harpoon Therapeutics removed from Best Ideas List at Wedbush
ITOS iTeos Therapeutics
$24.03 /

-1.24 (-4.91%)

04/12/21 Piper Sandler
iTeos Therapeutics' EOS-448 'competitive' in TIGIT class, says Piper Sandler
04/09/21 Piper Sandler
AACR abstracts a 'win' for iTeos Therapeutics, says Piper Sandler
04/05/21 Piper Sandler
Piper Sandler continues to recommend iTeos Therapeutics into data
03/25/21 Wedbush
iTeos Therapeutics price target raised to $52 from $46 at Wedbush
REPL Replimune Group
$30.50 /

+0.32 (+1.06%)

02/05/21 H.C. Wainwright
Replimune Group price target raised to $60 from $58 at H.C. Wainwright
11/17/20 BTIG
Replimune Group initiated with a Buy at BTIG
11/10/20 H.C. Wainwright
Replimune Group price target raised to $58 from $54 at H.C. Wainwright
RVMD Revolution Medicines
$39.79 /

+2.18 (+5.80%)

03/03/21 SVB Leerink
Revolution Medicines price target raised to $55 from $46 at SVB Leerink
01/29/21 JPMorgan
Revolution Medicines price target raised to $44 from $33 at JPMorgan
10/26/20 H.C. Wainwright
Revolution Medicines price target raised to $54 from $52 at H.C. Wainwright
09/14/20 Jefferies
Inhibrx initiated with a Buy at Jefferies
ZNTL Zentalis
$47.04 /

+1.43 (+3.14%)

04/12/21 SVB Leerink
Zentalis price target raised to $60 from $44 at SVB Leerink
03/26/21 H.C. Wainwright
Zentalis price target raised to $65 from $43 at H.C. Wainwright
01/19/21 Wedbush
Zentalis initiated with an Outperform at Wedbush
09/28/20 Cantor Fitzgerald
Cantor starts 'underappreciated' Zentalis with Overweight, $44 target
IMCR Immunocore
$39.50 /

+6.8 (+20.80%)

03/02/21 Jefferies
Immunocore initiated with a Buy at Jefferies
03/02/21 JPMorgan
Immunocore initiated with an Overweight at JPMorgan
03/02/21 Goldman Sachs
Immunocore initiated with a Neutral at Goldman Sachs
PMVP PMV Pharmaceuticals
$32.90 /

+0.06 (+0.18%)

10/20/20 Evercore ISI
PMV Pharmaceuticals initiated with an Outperform at Evercore ISI
10/20/20 BofA
PMV Pharmaceuticals initiated with a Buy at BofA
10/20/20 BofA
PMV Pharmaceuticals initiated with a Buy at BofA
10/20/20 Cowen
PMV Pharmaceuticals initiated with an Outperform at Cowen
ARVN Arvinas
$62.89 /

+1.62 (+2.64%)

03/31/21 BMO Capital
Arvinas initiated with an Outperform at BMO Capital
03/30/21 Cantor Fitzgerald
Arvinas price target raised to $140 from $121 at Cantor Fitzgerald
03/01/21 Roth Capital
Arvinas reaffirmed 'major catalysts' for 2021, says Roth Capital
01/19/21 Oppenheimer
Arvinas price target raised to $100 from $80 at Oppenheimer
IOVA Iovance Biotherapeutics
$30.00 /

-0.17 (-0.56%)

04/13/21 Cowen
Cowen starts Instil Bio at Outperform on 'second-mover advantage'
03/08/21 H.C. Wainwright
Iovance Biotherapeutics upgraded to Buy from Neutral at H.C. Wainwright
01/29/21 Baird
Iovance Biotherapeutics assumed at Outperform at Baird
01/14/21 Oppenheimer
Iovance Biotherapeutics price target raised to $57 from $43 at Oppenheimer
ADXS Advaxis
/

+

AGEN Agenus
$2.70 /

-0.015 (-0.55%)

04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
09/22/20 B. Riley
B. Riley FBR calls Agenus 'hidden gem' amidst ESMO data releases
09/18/20 Jefferies
Agenus price target raised to $8 from $5 at Jefferies
BPTH Bio-Path
$6.21 /

-0.41 (-6.19%)

04/06/21 H.C. Wainwright
Bio-Path price target raised to $12 from $10 at H.C. Wainwright
04/05/21 Roth Capital
Bio-Path triple regimen data 'highly favorable,' says Roth Capital
03/11/21 Roth Capital
Bio-Path Holdings initiated with a Buy at Roth Capital
11/16/20 H.C. Wainwright
Bio-Path Holdings price target lowered to $10 from $12 at H.C. Wainwright
INCY Incyte
$82.13 /

+1.5 (+1.86%)

02/10/21 SVB Leerink
Incyte downgraded to Market Perform from Outperform at SVB Leerink
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/04/21 Guggenheim
Incyte upgraded to Buy from Neutral at Guggenheim
IMAB I-MAB
$55.17 /

+5.42 (+10.89%)

03/15/21 Needham
I-MAB initiated with a Buy at Needham
03/03/21 H.C. Wainwright
I-MAB price target raised to $75 from $55 at H.C. Wainwright
02/25/21
Fly Intel: Top five analyst initiations
02/25/21 Piper Sandler
I-MAB initiated with an Overweight at Piper Sandler
MRSN Mersana Therapeutics
$17.06 /

+0.89 (+5.50%)

03/30/21 Credit Suisse
Mersana Therapeutics initiated with a Neutral at Credit Suisse
03/30/21 Credit Suisse
Mersana Therapeutics initiated with a Neutral at Credit Suisse
12/02/20 Stifel
Mersana Therapeutics initiated with a Buy at Stifel
09/29/20 JPMorgan
Mersana Therapeutics resumed with a Neutral at JPMorgan
RUBY Rubius Therapeutics
$23.77 /

+1.27 (+5.64%)

03/15/21 H.C. Wainwright
Rubius Therapeutics price target raised to $40 from $28 at H.C. Wainwright
10/14/20 JPMorgan
Rubius Therapeutics resumed with a Neutral at JPMorgan
PPBT Purple Biotech
$4.04 /

+ (+0.00%)

12/31/20 H.C. Wainwright
H.C. Wainwright reiterates Buy, $25 price target on Purple Biotech
SONN Sonnet BioTherapeutics
$2.11 /

-0.02 (-0.94%)

09/04/20 Chardan
Sonnet BioTherapeutics price target raised to $8 from $7 at Chardan
06/05/20 Chardan
Sonnet BioTherapeutics initiated with a Buy at Chardan
STTK Shattuck Labs
$32.98 /

+0.56 (+1.73%)

04/14/21 Berenberg
Shattuck Labs initiated with a Buy at Berenberg
01/20/21 Citi
Shattuck Labs price target raised to $75 from $36 at Citi
01/11/21 Evercore ISI
Shattuck Labs initiated with an Outperform at Evercore ISI
11/03/20 Needham
Shattuck Labs initiated with a Buy at Needham
SURF Surface Oncology
$7.35 /

+0.095 (+1.31%)

03/10/21 Wedbush
Surface Oncology risk/reward 'highly favorable' into data, says Wedbush
12/18/20 H.C. Wainwright
Surface Oncology price target raised to $15 from $11 at H.C. Wainwright
09/04/20
Fly Intel: Top five analyst initiations
09/04/20 H.C. Wainwright
Surface Oncology initiated with a Buy at H.C. Wainwright
BGNE BeiGene
$300.84 /

+0.84 (+0.28%)

03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
03/01/21
Fly Intel: Top five analyst downgrades
CMPI Checkmate Pharmaceuticals
$7.44 /

+0.3 (+4.20%)

03/19/21 Jefferies
Checkmate Pharmaceuticals price target lowered to $19 from $23 at Jefferies
09/01/20 Jefferies
Checkmate Pharmaceuticals initiated with a Buy at Jefferies
09/01/20 BofA
BofA starts Checkmate Pharmaceuticals at Neutral ahead of more 'de-risking'
09/01/20 BofA
Checkmate Pharmaceuticals initiated with a Neutral at BofA
BNGO Bionano Genomics
$6.42 /

-0.47 (-6.82%)

02/08/21 Oppenheimer
Bionano Genomics price target raised to $15 from $1.50 at Oppenheimer
01/26/21 Ladenburg
Bionano Genomics price target raised to $14 from $1.25 at Ladenburg
01/22/21 Maxim
Bionano Genomics price target raised to $14 from $2 at Maxim
12/04/20 Roth Capital
Bionano Genomics downgraded to Neutral from Buy at Roth Capital
ZNTL Zentalis
$47.04 /

+1.43 (+3.14%)

SURF Surface Oncology
$7.35 /

+0.095 (+1.31%)

STTK Shattuck Labs
$32.98 /

+0.56 (+1.73%)

RVMD Revolution Medicines
$39.79 /

+2.18 (+5.80%)

RUBY Rubius Therapeutics
$23.77 /

+1.27 (+5.64%)

REPL Replimune Group
$30.50 /

+0.32 (+1.06%)

PMVP PMV Pharmaceuticals
$32.90 /

+0.06 (+0.18%)

MRSN Mersana Therapeutics
$17.06 /

+0.89 (+5.50%)

JNCE Jounce Therapeutics
$9.74 /

+0.485 (+5.24%)

ITOS iTeos Therapeutics
$24.03 /

-1.24 (-4.91%)

IOVA Iovance Biotherapeutics
$30.00 /

-0.17 (-0.56%)

INCY Incyte
$82.13 /

+1.5 (+1.86%)

IMCR Immunocore
$39.50 /

+6.8 (+20.80%)

HARP Harpoon Therapeutics
$20.61 /

+0.73 (+3.67%)

CRSP Crispr Therapeutics
$123.29 /

+2.34 (+1.93%)

CMPI Checkmate Pharmaceuticals
$7.44 /

+0.3 (+4.20%)

BPTH Bio-Path
$6.21 /

-0.41 (-6.19%)

BNGO Bionano Genomics
$6.42 /

-0.47 (-6.82%)

BGNE BeiGene
$300.84 /

+0.84 (+0.28%)

BDTX Black Diamond Therapeutics
$24.70 /

-0.7199 (-2.83%)

ARVN Arvinas
$62.89 /

+1.62 (+2.64%)

AGEN Agenus
$2.70 /

-0.015 (-0.55%)

ADXS Advaxis
/

+

  • 17
    Mar
  • 10
    Mar
  • 16
    Feb
  • 09
    Feb
  • 04
    Feb
  • 05
    Feb
  • 20
    Jan
  • 13
    Jan
  • 08
    Jan
  • 07
    Jan
  • 18
    Dec
  • 16
    Dec
  • 02
    Dec
  • 24
    Nov
  • 22
    Oct
  • 09
    Oct
  • 25
    Sep
  • 25
    Sep
  • 07
    Aug
  • 30
    Jul
  • 24
    Jul
  • 09
    Jul
  • 01
    Jul
  • 17
    Jun
  • 09
    Jun
  • 29
    May
  • 29
    May
  • 22
    Apr
INCY Incyte
$82.13 /

+1.5 (+1.86%)

GLSI Greenwich LifeSciences
$35.13 /

-0.92 (-2.55%)

SURF Surface Oncology
$7.35 /

+0.095 (+1.31%)

RVMD Revolution Medicines
$39.79 /

+2.18 (+5.80%)

RUBY Rubius Therapeutics
$23.77 /

+1.27 (+5.64%)

REPL Replimune Group
$30.50 /

+0.32 (+1.06%)

MRSN Mersana Therapeutics
$17.06 /

+0.89 (+5.50%)

JNCE Jounce Therapeutics
$9.74 /

+0.485 (+5.24%)

INCY Incyte
$82.13 /

+1.5 (+1.86%)

IMCR Immunocore
$39.50 /

+6.8 (+20.80%)

HARP Harpoon Therapeutics
$20.61 /

+0.73 (+3.67%)

GLSI Greenwich LifeSciences
$35.13 /

-0.92 (-2.55%)

CRSP Crispr Therapeutics
$123.29 /

+2.34 (+1.93%)

BNGO Bionano Genomics
$6.42 /

-0.47 (-6.82%)

ATNM Actinium Pharmaceuticals
$7.80 /

+0.23 (+3.04%)

ARVN Arvinas
$62.89 /

+1.62 (+2.64%)

ZNTL Zentalis
$47.04 /

+1.43 (+3.14%)

RVMD Revolution Medicines
$39.79 /

+2.18 (+5.80%)

REPL Replimune Group
$30.50 /

+0.32 (+1.06%)

PPBT Purple Biotech
$4.04 /

+ (+0.00%)

PMVP PMV Pharmaceuticals
$32.90 /

+0.06 (+0.18%)

INCY Incyte
$82.13 /

+1.5 (+1.86%)

CRSP Crispr Therapeutics
$123.29 /

+2.34 (+1.93%)

BNGO Bionano Genomics
$6.42 /

-0.47 (-6.82%)

BDTX Black Diamond Therapeutics
$24.70 /

-0.7199 (-2.83%)

Conference/Events
American Association for Cancer Research to hold a virtual meeting » 04:55
04/14/21
04/14
04:55
04/14/21
04:55
MDGEF

MediGene

$4.80 /

+ (+0.00%)

, GLSI

Greenwich LifeSciences

$35.97 /

-3.06 (-7.84%)

, JNCE

Jounce Therapeutics

$9.25 /

+0.13 (+1.43%)

, ATNM

Actinium Pharmaceuticals

$7.57 /

-0.23 (-2.95%)

, BDTX

Black Diamond Therapeutics

$25.51 /

+0.94 (+3.83%)

, CRSP

Crispr Therapeutics

$120.95 /

+6.56 (+5.73%)

, HARP

Harpoon Therapeutics

$19.88 /

-0.54 (-2.64%)

, ITOS

iTeos Therapeutics

$24.95 /

+0.89 (+3.70%)

, REPL

Replimune Group

$30.27 /

+0.985 (+3.36%)

, RVMD

Revolution Medicines

$37.61 /

-1.69 (-4.30%)

, ZNTL

Zentalis

$45.62 /

+5.43 (+13.51%)

, IMCR

Immunocore

$32.75 /

+0.53 (+1.64%)

, PMVP

PMV Pharmaceuticals

$32.82 /

+1.88 (+6.08%)

, ARVN

Arvinas

$61.27 /

+0.79 (+1.31%)

, IOVA

Iovance Biotherapeutics

$30.17 /

+0.76 (+2.58%)

, ADXS

Advaxis

/

+

, AGEN

Agenus

$2.71 /

+0.045 (+1.69%)

, BPTH

Bio-Path

$6.60 /

+0.29 (+4.60%)

, INCY

Incyte

$80.61 /

+0.78 (+0.98%)

, IMAB

I-MAB

$49.75 /

+2.05 (+4.30%)

, MRSN

Mersana Therapeutics

$16.17 /

+0.315 (+1.99%)

, RUBY

Rubius Therapeutics

$22.60 /

+0.35 (+1.57%)

, PPBT

Purple Biotech

$4.04 /

-0.02 (-0.49%)

, SONN

Sonnet BioTherapeutics

$2.13 /

+ (+0.00%)

, STTK

Shattuck Labs

$32.42 /

+1.795 (+5.86%)

, SURF

Surface Oncology

$7.25 /

+0.025 (+0.35%)

, BGNE

BeiGene

$300.00 /

+5.01 (+1.70%)

, CMPI

Checkmate Pharmaceuticals

$7.15 /

-1.39 (-16.28%)

, BNGO

Bionano Genomics

$6.89 /

+0.145 (+2.15%)

AACR Virtual Annual…

AACR Virtual Annual Meeting 2021 will be held on April 9-15. Webcast Link

ShowHide Related Items >><<
ZNTL Zentalis
$45.62 /

+5.43 (+13.51%)

SURF Surface Oncology
$7.25 /

+0.025 (+0.35%)

STTK Shattuck Labs
$32.42 /

+1.795 (+5.86%)

SONN Sonnet BioTherapeutics
$2.13 /

+ (+0.00%)

RVMD Revolution Medicines
$37.61 /

-1.69 (-4.30%)

RUBY Rubius Therapeutics
$22.60 /

+0.35 (+1.57%)

REPL Replimune Group
$30.27 /

+0.985 (+3.36%)

PPBT Purple Biotech
$4.04 /

-0.02 (-0.49%)

PMVP PMV Pharmaceuticals
$32.82 /

+1.88 (+6.08%)

MRSN Mersana Therapeutics
$16.17 /

+0.315 (+1.99%)

JNCE Jounce Therapeutics
$9.25 /

+0.13 (+1.43%)

ITOS iTeos Therapeutics
$24.95 /

+0.89 (+3.70%)

IOVA Iovance Biotherapeutics
$30.17 /

+0.76 (+2.58%)

INCY Incyte
$80.61 /

+0.78 (+0.98%)

IMCR Immunocore
$32.75 /

+0.53 (+1.64%)

IMAB I-MAB
$49.75 /

+2.05 (+4.30%)

HARP Harpoon Therapeutics
$19.88 /

-0.54 (-2.64%)

GLSI Greenwich LifeSciences
$35.97 /

-3.06 (-7.84%)

CRSP Crispr Therapeutics
$120.95 /

+6.56 (+5.73%)

CMPI Checkmate Pharmaceuticals
$7.15 /

-1.39 (-16.28%)

BPTH Bio-Path
$6.60 /

+0.29 (+4.60%)

BNGO Bionano Genomics
$6.89 /

+0.145 (+2.15%)

BGNE BeiGene
$300.00 /

+5.01 (+1.70%)

BDTX Black Diamond Therapeutics
$25.51 /

+0.94 (+3.83%)

ATNM Actinium Pharmaceuticals
$7.57 /

-0.23 (-2.95%)

ARVN Arvinas
$61.27 /

+0.79 (+1.31%)

AGEN Agenus
$2.71 /

+0.045 (+1.69%)

ADXS Advaxis
/

+

MDGEF MediGene
$4.80 /

+ (+0.00%)

GLSI Greenwich LifeSciences
$35.97 /

-3.06 (-7.84%)

JNCE Jounce Therapeutics
$9.25 /

+0.13 (+1.43%)

04/12/21 Roth Capital
Jounce reported 'very robust' JTX-8064 analysis, says Roth Capital
03/14/21 Piper Sandler
Jounce Therapeutics initiated with an Overweight at Piper Sandler
02/26/21 H.C. Wainwright
Jounce Therapeutics price target raised to $15 from $11 at H.C. Wainwright
12/04/20 H.C. Wainwright
Jounce Therapeutics assumed with a Buy at H.C. Wainwright
ATNM Actinium Pharmaceuticals
$7.57 /

-0.23 (-2.95%)

04/06/21 William Blair
Actinium's Q4 net loss roughly in line with projected loss, says William Blair
12/29/20 H.C. Wainwright
H.C. Wainwright keeps Buy on Actinium amid 'headline disappointment'
12/29/20 JonesTrading
Actinium selloff today 'clear buying opportunity,' says JonesTrading
11/05/20
Fly Intel: Top five analyst initiations
BDTX Black Diamond Therapeutics
$25.51 /

+0.94 (+3.83%)

03/29/21 Wedbush
Black Diamond Therapeutics added to Best Ideas List at Wedbush
01/07/21 Wedbush
Wedbush bullish on Black Diamond Therapeutics, initiates with an Outperform
01/06/21 Wedbush
Black Diamond Therapeutics initiated with an Outperform at Wedbush
11/24/20 Berenberg
Black Diamond Therapeutics initiated with a Buy at Berenberg
CRSP Crispr Therapeutics
$120.95 /

+6.56 (+5.73%)

03/17/21 Guggenheim
Editas Medicine assumed with a Neutral at Guggenheim
03/04/21 JMP Securities
Crispr Therapeutics initiated with an Outperform at JMP Securities
03/01/21 Barclays
Crispr Therapeutics price target raised to $140 from $113 at Barclays
02/17/21 Goldman Sachs
Crispr Therapeutics price target lowered to $189 from $193 at Goldman Sachs
HARP Harpoon Therapeutics
$19.88 /

-0.54 (-2.64%)

03/11/21 Roth Capital
Harpoon's 2020/2021 should be 'festival of data,' says Roth Capital
01/04/21 Roth Capital
Harpoon having fourth candidate in clinic 'impressive,' says Roth Capital
12/23/20 H.C. Wainwright
Harpoon Therapeutics assumed with a Buy at H.C. Wainwright
12/16/20 Wedbush
Replimune Group, Harpoon Therapeutics removed from Best Ideas List at Wedbush
ITOS iTeos Therapeutics
$24.95 /

+0.89 (+3.70%)

04/12/21 Piper Sandler
iTeos Therapeutics' EOS-448 'competitive' in TIGIT class, says Piper Sandler
04/09/21 Piper Sandler
AACR abstracts a 'win' for iTeos Therapeutics, says Piper Sandler
04/05/21 Piper Sandler
Piper Sandler continues to recommend iTeos Therapeutics into data
03/25/21 Wedbush
iTeos Therapeutics price target raised to $52 from $46 at Wedbush
REPL Replimune Group
$30.27 /

+0.985 (+3.36%)

02/05/21 H.C. Wainwright
Replimune Group price target raised to $60 from $58 at H.C. Wainwright
11/17/20 BTIG
Replimune Group initiated with a Buy at BTIG
11/10/20 H.C. Wainwright
Replimune Group price target raised to $58 from $54 at H.C. Wainwright
RVMD Revolution Medicines
$37.61 /

-1.69 (-4.30%)

03/03/21 SVB Leerink
Revolution Medicines price target raised to $55 from $46 at SVB Leerink
01/29/21 JPMorgan
Revolution Medicines price target raised to $44 from $33 at JPMorgan
10/26/20 H.C. Wainwright
Revolution Medicines price target raised to $54 from $52 at H.C. Wainwright
09/14/20 Jefferies
Inhibrx initiated with a Buy at Jefferies
ZNTL Zentalis
$45.62 /

+5.43 (+13.51%)

04/12/21 SVB Leerink
Zentalis price target raised to $60 from $44 at SVB Leerink
03/26/21 H.C. Wainwright
Zentalis price target raised to $65 from $43 at H.C. Wainwright
01/19/21 Wedbush
Zentalis initiated with an Outperform at Wedbush
09/28/20 Cantor Fitzgerald
Cantor starts 'underappreciated' Zentalis with Overweight, $44 target
IMCR Immunocore
$32.75 /

+0.53 (+1.64%)

03/02/21 Jefferies
Immunocore initiated with a Buy at Jefferies
03/02/21 JPMorgan
Immunocore initiated with an Overweight at JPMorgan
03/02/21 Goldman Sachs
Immunocore initiated with a Neutral at Goldman Sachs
PMVP PMV Pharmaceuticals
$32.82 /

+1.88 (+6.08%)

10/20/20 Evercore ISI
PMV Pharmaceuticals initiated with an Outperform at Evercore ISI
10/20/20 BofA
PMV Pharmaceuticals initiated with a Buy at BofA
10/20/20 BofA
PMV Pharmaceuticals initiated with a Buy at BofA
10/20/20 Cowen
PMV Pharmaceuticals initiated with an Outperform at Cowen
ARVN Arvinas
$61.27 /

+0.79 (+1.31%)

03/31/21 BMO Capital
Arvinas initiated with an Outperform at BMO Capital
03/30/21 Cantor Fitzgerald
Arvinas price target raised to $140 from $121 at Cantor Fitzgerald
03/01/21 Roth Capital
Arvinas reaffirmed 'major catalysts' for 2021, says Roth Capital
01/19/21 Oppenheimer
Arvinas price target raised to $100 from $80 at Oppenheimer
IOVA Iovance Biotherapeutics
$30.17 /

+0.76 (+2.58%)

04/13/21 Cowen
Cowen starts Instil Bio at Outperform on 'second-mover advantage'
03/08/21 H.C. Wainwright
Iovance Biotherapeutics upgraded to Buy from Neutral at H.C. Wainwright
01/29/21 Baird
Iovance Biotherapeutics assumed at Outperform at Baird
01/14/21 Oppenheimer
Iovance Biotherapeutics price target raised to $57 from $43 at Oppenheimer
ADXS Advaxis
/

+

AGEN Agenus
$2.71 /

+0.045 (+1.69%)

04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
09/22/20 B. Riley
B. Riley FBR calls Agenus 'hidden gem' amidst ESMO data releases
09/18/20 Jefferies
Agenus price target raised to $8 from $5 at Jefferies
BPTH Bio-Path
$6.60 /

+0.29 (+4.60%)

04/06/21 H.C. Wainwright
Bio-Path price target raised to $12 from $10 at H.C. Wainwright
04/05/21 Roth Capital
Bio-Path triple regimen data 'highly favorable,' says Roth Capital
03/11/21 Roth Capital
Bio-Path Holdings initiated with a Buy at Roth Capital
11/16/20 H.C. Wainwright
Bio-Path Holdings price target lowered to $10 from $12 at H.C. Wainwright
INCY Incyte
$80.61 /

+0.78 (+0.98%)

02/10/21 SVB Leerink
Incyte downgraded to Market Perform from Outperform at SVB Leerink
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/04/21 Guggenheim
Incyte upgraded to Buy from Neutral at Guggenheim
IMAB I-MAB
$49.75 /

+2.05 (+4.30%)

03/15/21 Needham
I-MAB initiated with a Buy at Needham
03/03/21 H.C. Wainwright
I-MAB price target raised to $75 from $55 at H.C. Wainwright
02/25/21
Fly Intel: Top five analyst initiations
02/25/21 Piper Sandler
I-MAB initiated with an Overweight at Piper Sandler
MRSN Mersana Therapeutics
$16.17 /

+0.315 (+1.99%)

03/30/21 Credit Suisse
Mersana Therapeutics initiated with a Neutral at Credit Suisse
03/30/21 Credit Suisse
Mersana Therapeutics initiated with a Neutral at Credit Suisse
12/02/20 Stifel
Mersana Therapeutics initiated with a Buy at Stifel
09/29/20 JPMorgan
Mersana Therapeutics resumed with a Neutral at JPMorgan
RUBY Rubius Therapeutics
$22.60 /

+0.35 (+1.57%)

03/15/21 H.C. Wainwright
Rubius Therapeutics price target raised to $40 from $28 at H.C. Wainwright
10/14/20 JPMorgan
Rubius Therapeutics resumed with a Neutral at JPMorgan
PPBT Purple Biotech
$4.04 /

-0.02 (-0.49%)

12/31/20 H.C. Wainwright
H.C. Wainwright reiterates Buy, $25 price target on Purple Biotech
SONN Sonnet BioTherapeutics
$2.13 /

+ (+0.00%)

09/04/20 Chardan
Sonnet BioTherapeutics price target raised to $8 from $7 at Chardan
06/05/20 Chardan
Sonnet BioTherapeutics initiated with a Buy at Chardan
STTK Shattuck Labs
$32.42 /

+1.795 (+5.86%)

01/20/21 Citi
Shattuck Labs price target raised to $75 from $36 at Citi
01/11/21 Evercore ISI
Shattuck Labs initiated with an Outperform at Evercore ISI
11/03/20 Needham
Shattuck Labs initiated with a Buy at Needham
11/03/20 Citi
Shattuck Labs initiated with a Buy at Citi
SURF Surface Oncology
$7.25 /

+0.025 (+0.35%)

03/10/21 Wedbush
Surface Oncology risk/reward 'highly favorable' into data, says Wedbush
12/18/20 H.C. Wainwright
Surface Oncology price target raised to $15 from $11 at H.C. Wainwright
09/04/20
Fly Intel: Top five analyst initiations
09/04/20 H.C. Wainwright
Surface Oncology initiated with a Buy at H.C. Wainwright
BGNE BeiGene
$300.00 /

+5.01 (+1.70%)

03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
03/01/21
Fly Intel: Top five analyst downgrades
CMPI Checkmate Pharmaceuticals
$7.15 /

-1.39 (-16.28%)

03/19/21 Jefferies
Checkmate Pharmaceuticals price target lowered to $19 from $23 at Jefferies
09/01/20 Jefferies
Checkmate Pharmaceuticals initiated with a Buy at Jefferies
09/01/20 BofA
BofA starts Checkmate Pharmaceuticals at Neutral ahead of more 'de-risking'
09/01/20 BofA
Checkmate Pharmaceuticals initiated with a Neutral at BofA
BNGO Bionano Genomics
$6.89 /

+0.145 (+2.15%)

02/08/21 Oppenheimer
Bionano Genomics price target raised to $15 from $1.50 at Oppenheimer
01/26/21 Ladenburg
Bionano Genomics price target raised to $14 from $1.25 at Ladenburg
01/22/21 Maxim
Bionano Genomics price target raised to $14 from $2 at Maxim
12/04/20 Roth Capital
Bionano Genomics downgraded to Neutral from Buy at Roth Capital
ZNTL Zentalis
$45.62 /

+5.43 (+13.51%)

SURF Surface Oncology
$7.25 /

+0.025 (+0.35%)

STTK Shattuck Labs
$32.42 /

+1.795 (+5.86%)

RVMD Revolution Medicines
$37.61 /

-1.69 (-4.30%)

RUBY Rubius Therapeutics
$22.60 /

+0.35 (+1.57%)

REPL Replimune Group
$30.27 /

+0.985 (+3.36%)

PMVP PMV Pharmaceuticals
$32.82 /

+1.88 (+6.08%)

MRSN Mersana Therapeutics
$16.17 /

+0.315 (+1.99%)

JNCE Jounce Therapeutics
$9.25 /

+0.13 (+1.43%)

ITOS iTeos Therapeutics
$24.95 /

+0.89 (+3.70%)

IOVA Iovance Biotherapeutics
$30.17 /

+0.76 (+2.58%)

INCY Incyte
$80.61 /

+0.78 (+0.98%)

IMCR Immunocore
$32.75 /

+0.53 (+1.64%)

HARP Harpoon Therapeutics
$19.88 /

-0.54 (-2.64%)

CRSP Crispr Therapeutics
$120.95 /

+6.56 (+5.73%)

CMPI Checkmate Pharmaceuticals
$7.15 /

-1.39 (-16.28%)

BPTH Bio-Path
$6.60 /

+0.29 (+4.60%)

BNGO Bionano Genomics
$6.89 /

+0.145 (+2.15%)

BGNE BeiGene
$300.00 /

+5.01 (+1.70%)

BDTX Black Diamond Therapeutics
$25.51 /

+0.94 (+3.83%)

ARVN Arvinas
$61.27 /

+0.79 (+1.31%)

AGEN Agenus
$2.71 /

+0.045 (+1.69%)

ADXS Advaxis
/

+

  • 17
    Mar
  • 10
    Mar
  • 16
    Feb
  • 09
    Feb
  • 04
    Feb
  • 05
    Feb
  • 20
    Jan
  • 13
    Jan
  • 08
    Jan
  • 07
    Jan
  • 18
    Dec
  • 16
    Dec
  • 02
    Dec
  • 24
    Nov
  • 22
    Oct
  • 09
    Oct
  • 25
    Sep
  • 25
    Sep
  • 07
    Aug
  • 30
    Jul
  • 24
    Jul
  • 09
    Jul
  • 01
    Jul
  • 17
    Jun
  • 09
    Jun
  • 29
    May
  • 29
    May
  • 22
    Apr
INCY Incyte
$80.61 /

+0.78 (+0.98%)

GLSI Greenwich LifeSciences
$35.97 /

-3.06 (-7.84%)

SURF Surface Oncology
$7.25 /

+0.025 (+0.35%)

RVMD Revolution Medicines
$37.61 /

-1.69 (-4.30%)

RUBY Rubius Therapeutics
$22.60 /

+0.35 (+1.57%)

REPL Replimune Group
$30.27 /

+0.985 (+3.36%)

MRSN Mersana Therapeutics
$16.17 /

+0.315 (+1.99%)

JNCE Jounce Therapeutics
$9.25 /

+0.13 (+1.43%)

INCY Incyte
$80.61 /

+0.78 (+0.98%)

IMCR Immunocore
$32.75 /

+0.53 (+1.64%)

HARP Harpoon Therapeutics
$19.88 /

-0.54 (-2.64%)

GLSI Greenwich LifeSciences
$35.97 /

-3.06 (-7.84%)

CRSP Crispr Therapeutics
$120.95 /

+6.56 (+5.73%)

BNGO Bionano Genomics
$6.89 /

+0.145 (+2.15%)

ATNM Actinium Pharmaceuticals
$7.57 /

-0.23 (-2.95%)

ARVN Arvinas
$61.27 /

+0.79 (+1.31%)

ZNTL Zentalis
$45.62 /

+5.43 (+13.51%)

RVMD Revolution Medicines
$37.61 /

-1.69 (-4.30%)

REPL Replimune Group
$30.27 /

+0.985 (+3.36%)

PPBT Purple Biotech
$4.04 /

-0.02 (-0.49%)

PMVP PMV Pharmaceuticals
$32.82 /

+1.88 (+6.08%)

INCY Incyte
$80.61 /

+0.78 (+0.98%)

CRSP Crispr Therapeutics
$120.95 /

+6.56 (+5.73%)

BNGO Bionano Genomics
$6.89 /

+0.145 (+2.15%)

BDTX Black Diamond Therapeutics
$25.51 /

+0.94 (+3.83%)

Over a month ago
Conference/Events
American Association for Cancer Research to hold a virtual meeting » 04:55
04/13/21
04/13
04:55
04/13/21
04:55
MDGEF

MediGene

$4.80 /

+ (+0.00%)

, GLSI

Greenwich LifeSciences

$39.03 /

-14.47 (-27.05%)

, JNCE

Jounce Therapeutics

$9.12 /

-0.64 (-6.56%)

, ATNM

Actinium Pharmaceuticals

$7.80 /

-0.3 (-3.70%)

, BDTX

Black Diamond Therapeutics

$24.76 /

+0.15 (+0.61%)

, CRSP

Crispr Therapeutics

$114.42 /

-1.27 (-1.10%)

, HARP

Harpoon Therapeutics

$20.31 /

-2.35 (-10.37%)

, ITOS

iTeos Therapeutics

$24.07 /

-2.84 (-10.56%)

, REPL

Replimune Group

$29.39 /

-0.65 (-2.16%)

, RVMD

Revolution Medicines

$39.30 /

-3.39 (-7.94%)

, ZNTL

Zentalis

$40.50 /

+3 (+8.00%)

, IMCR

Immunocore

$32.22 /

-3.28 (-9.24%)

, PMVP

PMV Pharmaceuticals

$31.09 /

-2.245 (-6.73%)

, ARVN

Arvinas

$60.49 /

-3.06 (-4.82%)

, IOVA

Iovance Biotherapeutics

$29.41 /

-0.74 (-2.45%)

, ADXS

Advaxis

/

+

, AGEN

Agenus

$2.67 /

-0.115 (-4.14%)

, BPTH

Bio-Path

$6.31 /

-0.45 (-6.66%)

, INCY

Incyte

$79.83 /

-0.12 (-0.15%)

, IMAB

I-MAB

$47.74 /

-3.76 (-7.30%)

, MRSN

Mersana Therapeutics

$15.85 /

+0.04 (+0.25%)

, RUBY

Rubius Therapeutics

$22.31 /

-1.61 (-6.73%)

, PPBT

Purple Biotech

$4.05 /

-0.27 (-6.25%)

, SONN

Sonnet BioTherapeutics

$2.13 /

-0.11 (-4.91%)

, STTK

Shattuck Labs

$30.59 /

+1.98 (+6.92%)

, SURF

Surface Oncology

$7.22 /

-0.71 (-8.95%)

, BGNE

BeiGene

$294.41 /

-14.14 (-4.58%)

, CMPI

Checkmate Pharmaceuticals

$8.37 /

-2.15 (-20.44%)

, BNGO

Bionano Genomics

$6.75 /

-0.535 (-7.34%)

AACR Virtual Annual…

AACR Virtual Annual Meeting 2021 will be held on April 9-15. Webcast Link

ShowHide Related Items >><<
ZNTL Zentalis
$40.50 /

+3 (+8.00%)

SURF Surface Oncology
$7.22 /

-0.71 (-8.95%)

STTK Shattuck Labs
$30.59 /

+1.98 (+6.92%)

SONN Sonnet BioTherapeutics
$2.13 /

-0.11 (-4.91%)

RVMD Revolution Medicines
$39.30 /

-3.39 (-7.94%)

RUBY Rubius Therapeutics
$22.31 /

-1.61 (-6.73%)

REPL Replimune Group
$29.39 /

-0.65 (-2.16%)

PPBT Purple Biotech
$4.05 /

-0.27 (-6.25%)

PMVP PMV Pharmaceuticals
$31.09 /

-2.245 (-6.73%)

MRSN Mersana Therapeutics
$15.85 /

+0.04 (+0.25%)

JNCE Jounce Therapeutics
$9.12 /

-0.64 (-6.56%)

ITOS iTeos Therapeutics
$24.07 /

-2.84 (-10.56%)

IOVA Iovance Biotherapeutics
$29.41 /

-0.74 (-2.45%)

INCY Incyte
$79.83 /

-0.12 (-0.15%)

IMCR Immunocore
$32.22 /

-3.28 (-9.24%)

IMAB I-MAB
$47.74 /

-3.76 (-7.30%)

HARP Harpoon Therapeutics
$20.31 /

-2.35 (-10.37%)

GLSI Greenwich LifeSciences
$39.03 /

-14.47 (-27.05%)

CRSP Crispr Therapeutics
$114.42 /

-1.27 (-1.10%)

CMPI Checkmate Pharmaceuticals
$8.37 /

-2.15 (-20.44%)

BPTH Bio-Path
$6.31 /

-0.45 (-6.66%)

BNGO Bionano Genomics
$6.75 /

-0.535 (-7.34%)

BGNE BeiGene
$294.41 /

-14.14 (-4.58%)

BDTX Black Diamond Therapeutics
$24.76 /

+0.15 (+0.61%)

ATNM Actinium Pharmaceuticals
$7.80 /

-0.3 (-3.70%)

ARVN Arvinas
$60.49 /

-3.06 (-4.82%)

AGEN Agenus
$2.67 /

-0.115 (-4.14%)

ADXS Advaxis
/

+

MDGEF MediGene
$4.80 /

+ (+0.00%)

GLSI Greenwich LifeSciences
$39.03 /

-14.47 (-27.05%)

JNCE Jounce Therapeutics
$9.12 /

-0.64 (-6.56%)

04/12/21 Roth Capital
Jounce reported 'very robust' JTX-8064 analysis, says Roth Capital
03/14/21 Piper Sandler
Jounce Therapeutics initiated with an Overweight at Piper Sandler
02/26/21 H.C. Wainwright
Jounce Therapeutics price target raised to $15 from $11 at H.C. Wainwright
12/04/20 H.C. Wainwright
Jounce Therapeutics assumed with a Buy at H.C. Wainwright
ATNM Actinium Pharmaceuticals
$7.80 /

-0.3 (-3.70%)

04/06/21 William Blair
Actinium's Q4 net loss roughly in line with projected loss, says William Blair
12/29/20 H.C. Wainwright
H.C. Wainwright keeps Buy on Actinium amid 'headline disappointment'
12/29/20 JonesTrading
Actinium selloff today 'clear buying opportunity,' says JonesTrading
11/05/20
Fly Intel: Top five analyst initiations
BDTX Black Diamond Therapeutics
$24.76 /

+0.15 (+0.61%)

03/29/21 Wedbush
Black Diamond Therapeutics added to Best Ideas List at Wedbush
01/07/21 Wedbush
Wedbush bullish on Black Diamond Therapeutics, initiates with an Outperform
01/06/21 Wedbush
Black Diamond Therapeutics initiated with an Outperform at Wedbush
11/24/20 Berenberg
Black Diamond Therapeutics initiated with a Buy at Berenberg
CRSP Crispr Therapeutics
$114.42 /

-1.27 (-1.10%)

03/17/21 Guggenheim
Editas Medicine assumed with a Neutral at Guggenheim
03/04/21 JMP Securities
Crispr Therapeutics initiated with an Outperform at JMP Securities
03/01/21 Barclays
Crispr Therapeutics price target raised to $140 from $113 at Barclays
02/17/21 Goldman Sachs
Crispr Therapeutics price target lowered to $189 from $193 at Goldman Sachs
HARP Harpoon Therapeutics
$20.31 /

-2.35 (-10.37%)

03/11/21 Roth Capital
Harpoon's 2020/2021 should be 'festival of data,' says Roth Capital
01/04/21 Roth Capital
Harpoon having fourth candidate in clinic 'impressive,' says Roth Capital
12/23/20 H.C. Wainwright
Harpoon Therapeutics assumed with a Buy at H.C. Wainwright
12/16/20 Wedbush
Replimune Group, Harpoon Therapeutics removed from Best Ideas List at Wedbush
ITOS iTeos Therapeutics
$24.07 /

-2.84 (-10.56%)

04/12/21 Piper Sandler
iTeos Therapeutics' EOS-448 'competitive' in TIGIT class, says Piper Sandler
04/09/21 Piper Sandler
AACR abstracts a 'win' for iTeos Therapeutics, says Piper Sandler
04/05/21 Piper Sandler
Piper Sandler continues to recommend iTeos Therapeutics into data
03/25/21 Wedbush
iTeos Therapeutics price target raised to $52 from $46 at Wedbush
REPL Replimune Group
$29.39 /

-0.65 (-2.16%)

02/05/21 H.C. Wainwright
Replimune Group price target raised to $60 from $58 at H.C. Wainwright
11/17/20 BTIG
Replimune Group initiated with a Buy at BTIG
11/10/20 H.C. Wainwright
Replimune Group price target raised to $58 from $54 at H.C. Wainwright
RVMD Revolution Medicines
$39.30 /

-3.39 (-7.94%)

03/03/21 SVB Leerink
Revolution Medicines price target raised to $55 from $46 at SVB Leerink
01/29/21 JPMorgan
Revolution Medicines price target raised to $44 from $33 at JPMorgan
10/26/20 H.C. Wainwright
Revolution Medicines price target raised to $54 from $52 at H.C. Wainwright
09/14/20 Jefferies
Inhibrx initiated with a Buy at Jefferies
ZNTL Zentalis
$40.50 /

+3 (+8.00%)

04/12/21 SVB Leerink
Zentalis price target raised to $60 from $44 at SVB Leerink
03/26/21 H.C. Wainwright
Zentalis price target raised to $65 from $43 at H.C. Wainwright
01/19/21 Wedbush
Zentalis initiated with an Outperform at Wedbush
09/28/20 Cantor Fitzgerald
Cantor starts 'underappreciated' Zentalis with Overweight, $44 target
IMCR Immunocore
$32.22 /

-3.28 (-9.24%)

03/02/21 Jefferies
Immunocore initiated with a Buy at Jefferies
03/02/21 JPMorgan
Immunocore initiated with an Overweight at JPMorgan
03/02/21 Goldman Sachs
Immunocore initiated with a Neutral at Goldman Sachs
PMVP PMV Pharmaceuticals
$31.09 /

-2.245 (-6.73%)

10/20/20 Evercore ISI
PMV Pharmaceuticals initiated with an Outperform at Evercore ISI
10/20/20 BofA
PMV Pharmaceuticals initiated with a Buy at BofA
10/20/20 BofA
PMV Pharmaceuticals initiated with a Buy at BofA
10/20/20 Cowen
PMV Pharmaceuticals initiated with an Outperform at Cowen
ARVN Arvinas
$60.49 /

-3.06 (-4.82%)

03/31/21 BMO Capital
Arvinas initiated with an Outperform at BMO Capital
03/30/21 Cantor Fitzgerald
Arvinas price target raised to $140 from $121 at Cantor Fitzgerald
03/01/21 Roth Capital
Arvinas reaffirmed 'major catalysts' for 2021, says Roth Capital
01/19/21 Oppenheimer
Arvinas price target raised to $100 from $80 at Oppenheimer
IOVA Iovance Biotherapeutics
$29.41 /

-0.74 (-2.45%)

03/08/21 H.C. Wainwright
Iovance Biotherapeutics upgraded to Buy from Neutral at H.C. Wainwright
01/29/21 Baird
Iovance Biotherapeutics assumed at Outperform at Baird
01/14/21 Oppenheimer
Iovance Biotherapeutics price target raised to $57 from $43 at Oppenheimer
12/17/20 Barclays
Iovance Biotherapeutics price target raised to $55 from $43 at Barclays
ADXS Advaxis
/

+

AGEN Agenus
$2.67 /

-0.115 (-4.14%)

04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
09/22/20 B. Riley
B. Riley FBR calls Agenus 'hidden gem' amidst ESMO data releases
09/18/20 Jefferies
Agenus price target raised to $8 from $5 at Jefferies
BPTH Bio-Path
$6.31 /

-0.45 (-6.66%)

04/06/21 H.C. Wainwright
Bio-Path price target raised to $12 from $10 at H.C. Wainwright
04/05/21 Roth Capital
Bio-Path triple regimen data 'highly favorable,' says Roth Capital
03/11/21 Roth Capital
Bio-Path Holdings initiated with a Buy at Roth Capital
11/16/20 H.C. Wainwright
Bio-Path Holdings price target lowered to $10 from $12 at H.C. Wainwright
INCY Incyte
$79.83 /

-0.12 (-0.15%)

02/10/21 SVB Leerink
Incyte downgraded to Market Perform from Outperform at SVB Leerink
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/04/21 Guggenheim
Incyte upgraded to Buy from Neutral at Guggenheim
IMAB I-MAB
$47.74 /

-3.76 (-7.30%)

03/15/21 Needham
I-MAB initiated with a Buy at Needham
03/03/21 H.C. Wainwright
I-MAB price target raised to $75 from $55 at H.C. Wainwright
02/25/21
Fly Intel: Top five analyst initiations
02/25/21 Piper Sandler
I-MAB initiated with an Overweight at Piper Sandler
MRSN Mersana Therapeutics
$15.85 /

+0.04 (+0.25%)

03/30/21 Credit Suisse
Mersana Therapeutics initiated with a Neutral at Credit Suisse
03/30/21 Credit Suisse
Mersana Therapeutics initiated with a Neutral at Credit Suisse
12/02/20 Stifel
Mersana Therapeutics initiated with a Buy at Stifel
09/29/20 JPMorgan
Mersana Therapeutics resumed with a Neutral at JPMorgan
RUBY Rubius Therapeutics
$22.31 /

-1.61 (-6.73%)

03/15/21 H.C. Wainwright
Rubius Therapeutics price target raised to $40 from $28 at H.C. Wainwright
10/14/20 JPMorgan
Rubius Therapeutics resumed with a Neutral at JPMorgan
PPBT Purple Biotech
$4.05 /

-0.27 (-6.25%)

12/31/20 H.C. Wainwright
H.C. Wainwright reiterates Buy, $25 price target on Purple Biotech
SONN Sonnet BioTherapeutics
$2.13 /

-0.11 (-4.91%)

09/04/20 Chardan
Sonnet BioTherapeutics price target raised to $8 from $7 at Chardan
06/05/20 Chardan
Sonnet BioTherapeutics initiated with a Buy at Chardan
STTK Shattuck Labs
$30.59 /

+1.98 (+6.92%)

01/20/21 Citi
Shattuck Labs price target raised to $75 from $36 at Citi
01/11/21 Evercore ISI
Shattuck Labs initiated with an Outperform at Evercore ISI
11/03/20 Needham
Shattuck Labs initiated with a Buy at Needham
11/03/20 Citi
Shattuck Labs initiated with a Buy at Citi
SURF Surface Oncology
$7.22 /

-0.71 (-8.95%)

03/10/21 Wedbush
Surface Oncology risk/reward 'highly favorable' into data, says Wedbush
12/18/20 H.C. Wainwright
Surface Oncology price target raised to $15 from $11 at H.C. Wainwright
09/04/20
Fly Intel: Top five analyst initiations
09/04/20 H.C. Wainwright
Surface Oncology initiated with a Buy at H.C. Wainwright
BGNE BeiGene
$294.41 /

-14.14 (-4.58%)

03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
03/01/21
Fly Intel: Top five analyst downgrades
CMPI Checkmate Pharmaceuticals
$8.37 /

-2.15 (-20.44%)

03/19/21 Jefferies
Checkmate Pharmaceuticals price target lowered to $19 from $23 at Jefferies
09/01/20 Jefferies
Checkmate Pharmaceuticals initiated with a Buy at Jefferies
09/01/20 BofA
BofA starts Checkmate Pharmaceuticals at Neutral ahead of more 'de-risking'
09/01/20 BofA
Checkmate Pharmaceuticals initiated with a Neutral at BofA
BNGO Bionano Genomics
$6.75 /

-0.535 (-7.34%)

02/08/21 Oppenheimer
Bionano Genomics price target raised to $15 from $1.50 at Oppenheimer
01/26/21 Ladenburg
Bionano Genomics price target raised to $14 from $1.25 at Ladenburg
01/22/21 Maxim
Bionano Genomics price target raised to $14 from $2 at Maxim
12/04/20 Roth Capital
Bionano Genomics downgraded to Neutral from Buy at Roth Capital
ZNTL Zentalis
$40.50 /

+3 (+8.00%)

SURF Surface Oncology
$7.22 /

-0.71 (-8.95%)

STTK Shattuck Labs
$30.59 /

+1.98 (+6.92%)

RVMD Revolution Medicines
$39.30 /

-3.39 (-7.94%)

RUBY Rubius Therapeutics
$22.31 /

-1.61 (-6.73%)

REPL Replimune Group
$29.39 /

-0.65 (-2.16%)

PMVP PMV Pharmaceuticals
$31.09 /

-2.245 (-6.73%)

MRSN Mersana Therapeutics
$15.85 /

+0.04 (+0.25%)

JNCE Jounce Therapeutics
$9.12 /

-0.64 (-6.56%)

ITOS iTeos Therapeutics
$24.07 /

-2.84 (-10.56%)

IOVA Iovance Biotherapeutics
$29.41 /

-0.74 (-2.45%)

INCY Incyte
$79.83 /

-0.12 (-0.15%)

IMCR Immunocore
$32.22 /

-3.28 (-9.24%)

HARP Harpoon Therapeutics
$20.31 /

-2.35 (-10.37%)

CRSP Crispr Therapeutics
$114.42 /

-1.27 (-1.10%)

CMPI Checkmate Pharmaceuticals
$8.37 /

-2.15 (-20.44%)

BPTH Bio-Path
$6.31 /

-0.45 (-6.66%)

BNGO Bionano Genomics
$6.75 /

-0.535 (-7.34%)

BGNE BeiGene
$294.41 /

-14.14 (-4.58%)

BDTX Black Diamond Therapeutics
$24.76 /

+0.15 (+0.61%)

ARVN Arvinas
$60.49 /

-3.06 (-4.82%)

AGEN Agenus
$2.67 /

-0.115 (-4.14%)

ADXS Advaxis
/

+

  • 17
    Mar
  • 10
    Mar
  • 16
    Feb
  • 09
    Feb
  • 04
    Feb
  • 05
    Feb
  • 20
    Jan
  • 13
    Jan
  • 08
    Jan
  • 07
    Jan
  • 18
    Dec
  • 16
    Dec
  • 02
    Dec
  • 24
    Nov
  • 22
    Oct
  • 09
    Oct
  • 25
    Sep
  • 25
    Sep
  • 07
    Aug
  • 30
    Jul
  • 24
    Jul
  • 09
    Jul
  • 01
    Jul
  • 17
    Jun
  • 09
    Jun
  • 29
    May
  • 29
    May
  • 22
    Apr
INCY Incyte
$79.83 /

-0.12 (-0.15%)

GLSI Greenwich LifeSciences
$39.03 /

-14.47 (-27.05%)

SURF Surface Oncology
$7.22 /

-0.71 (-8.95%)

RVMD Revolution Medicines
$39.30 /

-3.39 (-7.94%)

RUBY Rubius Therapeutics
$22.31 /

-1.61 (-6.73%)

REPL Replimune Group
$29.39 /

-0.65 (-2.16%)

MRSN Mersana Therapeutics
$15.85 /

+0.04 (+0.25%)

JNCE Jounce Therapeutics
$9.12 /

-0.64 (-6.56%)

INCY Incyte
$79.83 /

-0.12 (-0.15%)

IMCR Immunocore
$32.22 /

-3.28 (-9.24%)

HARP Harpoon Therapeutics
$20.31 /

-2.35 (-10.37%)

GLSI Greenwich LifeSciences
$39.03 /

-14.47 (-27.05%)

CRSP Crispr Therapeutics
$114.42 /

-1.27 (-1.10%)

BNGO Bionano Genomics
$6.75 /

-0.535 (-7.34%)

ATNM Actinium Pharmaceuticals
$7.80 /

-0.3 (-3.70%)

ARVN Arvinas
$60.49 /

-3.06 (-4.82%)

ZNTL Zentalis
$40.50 /

+3 (+8.00%)

RVMD Revolution Medicines
$39.30 /

-3.39 (-7.94%)

REPL Replimune Group
$29.39 /

-0.65 (-2.16%)

PPBT Purple Biotech
$4.05 /

-0.27 (-6.25%)

PMVP PMV Pharmaceuticals
$31.09 /

-2.245 (-6.73%)

INCY Incyte
$79.83 /

-0.12 (-0.15%)

CRSP Crispr Therapeutics
$114.42 /

-1.27 (-1.10%)

BNGO Bionano Genomics
$6.75 /

-0.535 (-7.34%)

BDTX Black Diamond Therapeutics
$24.76 /

+0.15 (+0.61%)

Conference/Events
Black Diamond Therapeutics participates in a conference call with Cowen » 13:25
04/12/21
04/12
13:25
04/12/21
13:25
BDTX

Black Diamond Therapeutics

$24.42 /

-0.19 (-0.77%)

Healthcare Analyst Frahm…

Healthcare Analyst Frahm holds a conference call with management on April 12 at 2 pm hosted by Cowen.

ShowHide Related Items >><<
BDTX Black Diamond Therapeutics
$24.42 /

-0.19 (-0.77%)

BDTX Black Diamond Therapeutics
$24.42 /

-0.19 (-0.77%)

03/29/21 Wedbush
Black Diamond Therapeutics added to Best Ideas List at Wedbush
01/07/21 Wedbush
Wedbush bullish on Black Diamond Therapeutics, initiates with an Outperform
01/06/21 Wedbush
Black Diamond Therapeutics initiated with an Outperform at Wedbush
11/24/20 Berenberg
Black Diamond Therapeutics initiated with a Buy at Berenberg
BDTX Black Diamond Therapeutics
$24.42 /

-0.19 (-0.77%)

BDTX Black Diamond Therapeutics
$24.42 /

-0.19 (-0.77%)

Conference/Events
American Association for Cancer Research to hold a virtual meeting » 04:55
04/12/21
04/12
04:55
04/12/21
04:55
MDGEF

MediGene

$4.80 /

+ (+0.00%)

, GLSI

Greenwich LifeSciences

$53.50 /

+4.21 (+8.54%)

, JNCE

Jounce Therapeutics

$9.76 /

-0.65 (-6.24%)

, ATNM

Actinium Pharmaceuticals

$8.10 /

-0.085 (-1.04%)

, BDTX

Black Diamond Therapeutics

$24.61 /

-0.31 (-1.24%)

, CRSP

Crispr Therapeutics

$115.49 /

-4.67 (-3.89%)

, HARP

Harpoon Therapeutics

$22.70 /

-0.03 (-0.13%)

, ITOS

iTeos Therapeutics

$26.99 /

-3.12 (-10.36%)

, REPL

Replimune Group

$30.04 /

-0.52 (-1.70%)

, RVMD

Revolution Medicines

$42.65 /

-2.46 (-5.45%)

, ZNTL

Zentalis

$37.35 /

-5.19 (-12.20%)

, IMCR

Immunocore

$35.01 /

-0.99 (-2.75%)

, PMVP

PMV Pharmaceuticals

$33.30 /

-0.605 (-1.78%)

, ARVN

Arvinas

$63.55 /

-0.83 (-1.29%)

, IOVA

Iovance Biotherapeutics

$30.17 /

-1.12 (-3.58%)

, ADXS

Advaxis

/

+

, AGEN

Agenus

$2.78 /

-0.01 (-0.36%)

, BPTH

Bio-Path

$6.79 /

-0.13 (-1.88%)

, INCY

Incyte

$79.97 /

-0.91 (-1.13%)

, IMAB

I-MAB

$51.50 /

-1.34 (-2.54%)

, MRSN

Mersana Therapeutics

$15.79 /

-0.27 (-1.68%)

, RUBY

Rubius Therapeutics

$23.92 /

-0.14 (-0.58%)

, PPBT

Purple Biotech

$4.31 /

+0.035 (+0.82%)

, SONN

Sonnet BioTherapeutics

$2.24 /

-0.05 (-2.18%)

, STTK

Shattuck Labs

$28.31 /

+1.365 (+5.07%)

, SURF

Surface Oncology

$7.93 /

-0.22 (-2.70%)

, BGNE

BeiGene

$308.27 /

-5.8 (-1.85%)

, CMPI

Checkmate Pharmaceuticals

$10.52 /

+0.14 (+1.35%)

, BNGO

Bionano Genomics

$7.29 /

-0.215 (-2.87%)

AACR Virtual Annual…

AACR Virtual Annual Meeting 2021 will be held on April 9-15. Webcast Link

ShowHide Related Items >><<
ZNTL Zentalis
$37.35 /

-5.19 (-12.20%)

SURF Surface Oncology
$7.93 /

-0.22 (-2.70%)

STTK Shattuck Labs
$28.31 /

+1.365 (+5.07%)

SONN Sonnet BioTherapeutics
$2.24 /

-0.05 (-2.18%)

RVMD Revolution Medicines
$42.65 /

-2.46 (-5.45%)

RUBY Rubius Therapeutics
$23.92 /

-0.14 (-0.58%)

REPL Replimune Group
$30.04 /

-0.52 (-1.70%)

PPBT Purple Biotech
$4.31 /

+0.035 (+0.82%)

PMVP PMV Pharmaceuticals
$33.30 /

-0.605 (-1.78%)

MRSN Mersana Therapeutics
$15.79 /

-0.27 (-1.68%)

JNCE Jounce Therapeutics
$9.76 /

-0.65 (-6.24%)

ITOS iTeos Therapeutics
$26.99 /

-3.12 (-10.36%)

IOVA Iovance Biotherapeutics
$30.17 /

-1.12 (-3.58%)

INCY Incyte
$79.97 /

-0.91 (-1.13%)

IMCR Immunocore
$35.01 /

-0.99 (-2.75%)

IMAB I-MAB
$51.50 /

-1.34 (-2.54%)

HARP Harpoon Therapeutics
$22.70 /

-0.03 (-0.13%)

GLSI Greenwich LifeSciences
$53.50 /

+4.21 (+8.54%)

CRSP Crispr Therapeutics
$115.49 /

-4.67 (-3.89%)

CMPI Checkmate Pharmaceuticals
$10.52 /

+0.14 (+1.35%)

BPTH Bio-Path
$6.79 /

-0.13 (-1.88%)

BNGO Bionano Genomics
$7.29 /

-0.215 (-2.87%)

BGNE BeiGene
$308.27 /

-5.8 (-1.85%)

BDTX Black Diamond Therapeutics
$24.61 /

-0.31 (-1.24%)

ATNM Actinium Pharmaceuticals
$8.10 /

-0.085 (-1.04%)

ARVN Arvinas
$63.55 /

-0.83 (-1.29%)

AGEN Agenus
$2.78 /

-0.01 (-0.36%)

ADXS Advaxis
/

+

MDGEF MediGene
$4.80 /

+ (+0.00%)

GLSI Greenwich LifeSciences
$53.50 /

+4.21 (+8.54%)

JNCE Jounce Therapeutics
$9.76 /

-0.65 (-6.24%)

03/14/21 Piper Sandler
Jounce Therapeutics initiated with an Overweight at Piper Sandler
02/26/21 H.C. Wainwright
Jounce Therapeutics price target raised to $15 from $11 at H.C. Wainwright
12/04/20 H.C. Wainwright
Jounce Therapeutics assumed with a Buy at H.C. Wainwright
11/10/20 Roth Capital
Jounce Therapeutics price target lowered to $15 from $28 at Roth Capital
ATNM Actinium Pharmaceuticals
$8.10 /

-0.085 (-1.04%)

04/06/21 William Blair
Actinium's Q4 net loss roughly in line with projected loss, says William Blair
12/29/20 H.C. Wainwright
H.C. Wainwright keeps Buy on Actinium amid 'headline disappointment'
12/29/20 JonesTrading
Actinium selloff today 'clear buying opportunity,' says JonesTrading
11/05/20
Fly Intel: Top five analyst initiations
BDTX Black Diamond Therapeutics
$24.61 /

-0.31 (-1.24%)

03/29/21 Wedbush
Black Diamond Therapeutics added to Best Ideas List at Wedbush
01/07/21 Wedbush
Wedbush bullish on Black Diamond Therapeutics, initiates with an Outperform
01/06/21 Wedbush
Black Diamond Therapeutics initiated with an Outperform at Wedbush
11/24/20 Berenberg
Black Diamond Therapeutics initiated with a Buy at Berenberg
CRSP Crispr Therapeutics
$115.49 /

-4.67 (-3.89%)

03/17/21 Guggenheim
Editas Medicine assumed with a Neutral at Guggenheim
03/04/21 JMP Securities
Crispr Therapeutics initiated with an Outperform at JMP Securities
03/01/21 Barclays
Crispr Therapeutics price target raised to $140 from $113 at Barclays
02/17/21 Goldman Sachs
Crispr Therapeutics price target lowered to $189 from $193 at Goldman Sachs
HARP Harpoon Therapeutics
$22.70 /

-0.03 (-0.13%)

03/11/21 Roth Capital
Harpoon's 2020/2021 should be 'festival of data,' says Roth Capital
01/04/21 Roth Capital
Harpoon having fourth candidate in clinic 'impressive,' says Roth Capital
12/23/20 H.C. Wainwright
Harpoon Therapeutics assumed with a Buy at H.C. Wainwright
12/16/20 Wedbush
Replimune Group, Harpoon Therapeutics removed from Best Ideas List at Wedbush
ITOS iTeos Therapeutics
$26.99 /

-3.12 (-10.36%)

04/09/21 Piper Sandler
AACR abstracts a 'win' for iTeos Therapeutics, says Piper Sandler
04/05/21 Piper Sandler
Piper Sandler continues to recommend iTeos Therapeutics into data
03/25/21 Wedbush
iTeos Therapeutics price target raised to $52 from $46 at Wedbush
10/07/20 Baird
iTeos Therapeutics initiated with an Outperform at Baird
REPL Replimune Group
$30.04 /

-0.52 (-1.70%)

02/05/21 H.C. Wainwright
Replimune Group price target raised to $60 from $58 at H.C. Wainwright
11/17/20 BTIG
Replimune Group initiated with a Buy at BTIG
11/10/20 H.C. Wainwright
Replimune Group price target raised to $58 from $54 at H.C. Wainwright
RVMD Revolution Medicines
$42.65 /

-2.46 (-5.45%)

03/03/21 SVB Leerink
Revolution Medicines price target raised to $55 from $46 at SVB Leerink
01/29/21 JPMorgan
Revolution Medicines price target raised to $44 from $33 at JPMorgan
10/26/20 H.C. Wainwright
Revolution Medicines price target raised to $54 from $52 at H.C. Wainwright
09/14/20 Jefferies
Inhibrx initiated with a Buy at Jefferies
ZNTL Zentalis
$37.35 /

-5.19 (-12.20%)

03/26/21 H.C. Wainwright
Zentalis price target raised to $65 from $43 at H.C. Wainwright
01/19/21 Wedbush
Zentalis initiated with an Outperform at Wedbush
09/28/20 Cantor Fitzgerald
Cantor starts 'underappreciated' Zentalis with Overweight, $44 target
09/28/20 Cantor Fitzgerald
Zentalis initiated with an Overweight at Cantor Fitzgerald
IMCR Immunocore
$35.01 /

-0.99 (-2.75%)

03/02/21 Jefferies
Immunocore initiated with a Buy at Jefferies
03/02/21 JPMorgan
Immunocore initiated with an Overweight at JPMorgan
03/02/21 Goldman Sachs
Immunocore initiated with a Neutral at Goldman Sachs
PMVP PMV Pharmaceuticals
$33.30 /

-0.605 (-1.78%)

10/20/20 Evercore ISI
PMV Pharmaceuticals initiated with an Outperform at Evercore ISI
10/20/20 BofA
PMV Pharmaceuticals initiated with a Buy at BofA
10/20/20 BofA
PMV Pharmaceuticals initiated with a Buy at BofA
10/20/20 Cowen
PMV Pharmaceuticals initiated with an Outperform at Cowen
ARVN Arvinas
$63.55 /

-0.83 (-1.29%)

03/31/21 BMO Capital
Arvinas initiated with an Outperform at BMO Capital
03/30/21 Cantor Fitzgerald
Arvinas price target raised to $140 from $121 at Cantor Fitzgerald
03/01/21 Roth Capital
Arvinas reaffirmed 'major catalysts' for 2021, says Roth Capital
01/19/21 Oppenheimer
Arvinas price target raised to $100 from $80 at Oppenheimer
IOVA Iovance Biotherapeutics
$30.17 /

-1.12 (-3.58%)

03/08/21 H.C. Wainwright
Iovance Biotherapeutics upgraded to Buy from Neutral at H.C. Wainwright
01/29/21 Baird
Iovance Biotherapeutics assumed at Outperform at Baird
01/14/21 Oppenheimer
Iovance Biotherapeutics price target raised to $57 from $43 at Oppenheimer
12/17/20 Barclays
Iovance Biotherapeutics price target raised to $55 from $43 at Barclays
ADXS Advaxis
/

+

AGEN Agenus
$2.78 /

-0.01 (-0.36%)

09/22/20 B. Riley
B. Riley FBR calls Agenus 'hidden gem' amidst ESMO data releases
09/18/20 Jefferies
Agenus price target raised to $8 from $5 at Jefferies
BPTH Bio-Path
$6.79 /

-0.13 (-1.88%)

04/06/21 H.C. Wainwright
Bio-Path price target raised to $12 from $10 at H.C. Wainwright
04/05/21 Roth Capital
Bio-Path triple regimen data 'highly favorable,' says Roth Capital
03/11/21 Roth Capital
Bio-Path Holdings initiated with a Buy at Roth Capital
11/16/20 H.C. Wainwright
Bio-Path Holdings price target lowered to $10 from $12 at H.C. Wainwright
INCY Incyte
$79.97 /

-0.91 (-1.13%)

02/10/21 SVB Leerink
Incyte downgraded to Market Perform from Outperform at SVB Leerink
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/04/21 Guggenheim
Incyte upgraded to Buy from Neutral at Guggenheim
IMAB I-MAB
$51.50 /

-1.34 (-2.54%)

03/15/21 Needham
I-MAB initiated with a Buy at Needham
03/03/21 H.C. Wainwright
I-MAB price target raised to $75 from $55 at H.C. Wainwright
02/25/21
Fly Intel: Top five analyst initiations
02/25/21 Piper Sandler
I-MAB initiated with an Overweight at Piper Sandler
MRSN Mersana Therapeutics
$15.79 /

-0.27 (-1.68%)

03/30/21 Credit Suisse
Mersana Therapeutics initiated with a Neutral at Credit Suisse
03/30/21 Credit Suisse
Mersana Therapeutics initiated with a Neutral at Credit Suisse
12/02/20 Stifel
Mersana Therapeutics initiated with a Buy at Stifel
09/29/20 JPMorgan
Mersana Therapeutics resumed with a Neutral at JPMorgan
RUBY Rubius Therapeutics
$23.92 /

-0.14 (-0.58%)

03/15/21 H.C. Wainwright
Rubius Therapeutics price target raised to $40 from $28 at H.C. Wainwright
10/14/20 JPMorgan
Rubius Therapeutics resumed with a Neutral at JPMorgan
PPBT Purple Biotech
$4.31 /

+0.035 (+0.82%)

12/31/20 H.C. Wainwright
H.C. Wainwright reiterates Buy, $25 price target on Purple Biotech
SONN Sonnet BioTherapeutics
$2.24 /

-0.05 (-2.18%)

09/04/20 Chardan
Sonnet BioTherapeutics price target raised to $8 from $7 at Chardan
06/05/20 Chardan
Sonnet BioTherapeutics initiated with a Buy at Chardan
STTK Shattuck Labs
$28.31 /

+1.365 (+5.07%)

01/20/21 Citi
Shattuck Labs price target raised to $75 from $36 at Citi
01/11/21 Evercore ISI
Shattuck Labs initiated with an Outperform at Evercore ISI
11/03/20 Needham
Shattuck Labs initiated with a Buy at Needham
11/03/20 Citi
Shattuck Labs initiated with a Buy at Citi
SURF Surface Oncology
$7.93 /

-0.22 (-2.70%)

03/10/21 Wedbush
Surface Oncology risk/reward 'highly favorable' into data, says Wedbush
12/18/20 H.C. Wainwright
Surface Oncology price target raised to $15 from $11 at H.C. Wainwright
09/04/20
Fly Intel: Top five analyst initiations
09/04/20 H.C. Wainwright
Surface Oncology initiated with a Buy at H.C. Wainwright
BGNE BeiGene
$308.27 /

-5.8 (-1.85%)

03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
03/01/21
Fly Intel: Top five analyst downgrades
CMPI Checkmate Pharmaceuticals
$10.52 /

+0.14 (+1.35%)

03/19/21 Jefferies
Checkmate Pharmaceuticals price target lowered to $19 from $23 at Jefferies
09/01/20 Jefferies
Checkmate Pharmaceuticals initiated with a Buy at Jefferies
09/01/20 BofA
BofA starts Checkmate Pharmaceuticals at Neutral ahead of more 'de-risking'
09/01/20 BofA
Checkmate Pharmaceuticals initiated with a Neutral at BofA
BNGO Bionano Genomics
$7.29 /

-0.215 (-2.87%)

02/08/21 Oppenheimer
Bionano Genomics price target raised to $15 from $1.50 at Oppenheimer
01/26/21 Ladenburg
Bionano Genomics price target raised to $14 from $1.25 at Ladenburg
01/22/21 Maxim
Bionano Genomics price target raised to $14 from $2 at Maxim
12/04/20 Roth Capital
Bionano Genomics downgraded to Neutral from Buy at Roth Capital
ZNTL Zentalis
$37.35 /

-5.19 (-12.20%)

SURF Surface Oncology
$7.93 /

-0.22 (-2.70%)

STTK Shattuck Labs
$28.31 /

+1.365 (+5.07%)

RVMD Revolution Medicines
$42.65 /

-2.46 (-5.45%)

RUBY Rubius Therapeutics
$23.92 /

-0.14 (-0.58%)

REPL Replimune Group
$30.04 /

-0.52 (-1.70%)

PMVP PMV Pharmaceuticals
$33.30 /

-0.605 (-1.78%)

MRSN Mersana Therapeutics
$15.79 /

-0.27 (-1.68%)

JNCE Jounce Therapeutics
$9.76 /

-0.65 (-6.24%)

ITOS iTeos Therapeutics
$26.99 /

-3.12 (-10.36%)

IOVA Iovance Biotherapeutics
$30.17 /

-1.12 (-3.58%)

INCY Incyte
$79.97 /

-0.91 (-1.13%)

IMCR Immunocore
$35.01 /

-0.99 (-2.75%)

HARP Harpoon Therapeutics
$22.70 /

-0.03 (-0.13%)

CRSP Crispr Therapeutics
$115.49 /

-4.67 (-3.89%)

CMPI Checkmate Pharmaceuticals
$10.52 /

+0.14 (+1.35%)

BPTH Bio-Path
$6.79 /

-0.13 (-1.88%)

BNGO Bionano Genomics
$7.29 /

-0.215 (-2.87%)

BGNE BeiGene
$308.27 /

-5.8 (-1.85%)

BDTX Black Diamond Therapeutics
$24.61 /

-0.31 (-1.24%)

ARVN Arvinas
$63.55 /

-0.83 (-1.29%)

AGEN Agenus
$2.78 /

-0.01 (-0.36%)

ADXS Advaxis
/

+

  • 17
    Mar
  • 10
    Mar
  • 16
    Feb
  • 09
    Feb
  • 04
    Feb
  • 05
    Feb
  • 20
    Jan
  • 13
    Jan
  • 08
    Jan
  • 07
    Jan
  • 18
    Dec
  • 16
    Dec
  • 02
    Dec
  • 24
    Nov
  • 22
    Oct
  • 09
    Oct
  • 25
    Sep
  • 25
    Sep
  • 07
    Aug
  • 30
    Jul
  • 24
    Jul
  • 09
    Jul
  • 01
    Jul
  • 17
    Jun
  • 09
    Jun
  • 29
    May
  • 29
    May
  • 22
    Apr
INCY Incyte
$79.97 /

-0.91 (-1.13%)

GLSI Greenwich LifeSciences
$53.50 /

+4.21 (+8.54%)

SURF Surface Oncology
$7.93 /

-0.22 (-2.70%)

RVMD Revolution Medicines
$42.65 /

-2.46 (-5.45%)

RUBY Rubius Therapeutics
$23.92 /

-0.14 (-0.58%)

REPL Replimune Group
$30.04 /

-0.52 (-1.70%)

MRSN Mersana Therapeutics
$15.79 /

-0.27 (-1.68%)

JNCE Jounce Therapeutics
$9.76 /

-0.65 (-6.24%)

INCY Incyte
$79.97 /

-0.91 (-1.13%)

IMCR Immunocore
$35.01 /

-0.99 (-2.75%)

HARP Harpoon Therapeutics
$22.70 /

-0.03 (-0.13%)

GLSI Greenwich LifeSciences
$53.50 /

+4.21 (+8.54%)

CRSP Crispr Therapeutics
$115.49 /

-4.67 (-3.89%)

BNGO Bionano Genomics
$7.29 /

-0.215 (-2.87%)

ATNM Actinium Pharmaceuticals
$8.10 /

-0.085 (-1.04%)

ARVN Arvinas
$63.55 /

-0.83 (-1.29%)

ZNTL Zentalis
$37.35 /

-5.19 (-12.20%)

RVMD Revolution Medicines
$42.65 /

-2.46 (-5.45%)

REPL Replimune Group
$30.04 /

-0.52 (-1.70%)

PPBT Purple Biotech
$4.31 /

+0.035 (+0.82%)

PMVP PMV Pharmaceuticals
$33.30 /

-0.605 (-1.78%)

INCY Incyte
$79.97 /

-0.91 (-1.13%)

CRSP Crispr Therapeutics
$115.49 /

-4.67 (-3.89%)

BNGO Bionano Genomics
$7.29 /

-0.215 (-2.87%)

BDTX Black Diamond Therapeutics
$24.61 /

-0.31 (-1.24%)

Conference/Events
Black Diamond Therapeutics participates in a conference call with Cowen » 04:55
04/12/21
04/12
04:55
04/12/21
04:55
BDTX

Black Diamond Therapeutics

$24.61 /

-0.31 (-1.24%)

Healthcare Analyst Frahm…

Healthcare Analyst Frahm holds a conference call with management on April 12 at 2 pm hosted by Cowen.

ShowHide Related Items >><<
BDTX Black Diamond Therapeutics
$24.61 /

-0.31 (-1.24%)

BDTX Black Diamond Therapeutics
$24.61 /

-0.31 (-1.24%)

03/29/21 Wedbush
Black Diamond Therapeutics added to Best Ideas List at Wedbush
01/07/21 Wedbush
Wedbush bullish on Black Diamond Therapeutics, initiates with an Outperform
01/06/21 Wedbush
Black Diamond Therapeutics initiated with an Outperform at Wedbush
11/24/20 Berenberg
Black Diamond Therapeutics initiated with a Buy at Berenberg
BDTX Black Diamond Therapeutics
$24.61 /

-0.31 (-1.24%)

BDTX Black Diamond Therapeutics
$24.61 /

-0.31 (-1.24%)

Hot Stocks
Black Diamond Therapeutics announces preclinical data on BDTX-189, BDTX-1535 » 16:06
04/11/21
04/11
16:06
04/11/21
16:06
BDTX

Black Diamond Therapeutics

$24.61 /

-0.31 (-1.24%)

Black Diamond…

Black Diamond Therapeutics announced the presentation of preclinical data on BDTX-189 and BDTX-1535 at the American Association for Cancer Research Annual Meeting. Preclinical PK BDTX-189 Data includes: Black Diamond employed a novel physiologically based pharmacokinetic (PBPK) modeling strategy, accounting for compound-specific determinants of BDTX-189 metabolism and disposition, to prospectively predict the clinical PK profile and active dose range of BDTX-189; Preclinical PBPK modeling indicated that BDTX-189 would be readily orally absorbed with a short elimination half-life while maintaining suppression of ErbB pathway biomarkers over the dosing interval, consistent with the irreversible mechanism of action and the desired PK/PD profile; Active dose levels in humans were projected to be in the 400-800 mg QD range based on the exposure-tumor growth inhibition relationship in multiple mouse patient-derived xenograft models harboring ErbB allosteric mutations; Enrollment and dosing of patients in the Phase 1/2 MasterKey-01 study of BDTX-189 is ongoing, and the Company is on track to complete the dose-escalation portion of the Phase 1 clinical trial in the first half of 2021. Preclinical BDTX-1535 Data includes: GBM tumors express a family of allosteric oncogenic EGFR variants that often appear together in GBM and, as shown by the Company's preclinical work, must all be effectively inhibited to secure a meaningful anti-tumor response. In cell-based assays, BDTX-1535 achieved potent and selective inhibition of all members of the family of oncogenic EGFR variants expressed in GBM; BDTX-1535 demonstrated a favorable brain-penetrant PK profile in mouse, rat, and dog models; Tumor growth inhibition in mouse models bearing intracranial GBM6 patient-derived tumors expressing allosteric EGFR mutants was achieved. BDTX-1535 demonstrated potent and selective inhibition of rare Exon 18 mutations and the C797S mutation, supporting the potential for utility beyond GBM, such as in NSCLC. Black Diamond expects to file an Investigational New Drug application for BDTX-1535 in the first half of 2022.

ShowHide Related Items >><<
BDTX Black Diamond Therapeutics
$24.61 /

-0.31 (-1.24%)

BDTX Black Diamond Therapeutics
$24.61 /

-0.31 (-1.24%)

03/29/21 Wedbush
Black Diamond Therapeutics added to Best Ideas List at Wedbush
01/07/21 Wedbush
Wedbush bullish on Black Diamond Therapeutics, initiates with an Outperform
01/06/21 Wedbush
Black Diamond Therapeutics initiated with an Outperform at Wedbush
11/24/20 Berenberg
Black Diamond Therapeutics initiated with a Buy at Berenberg
BDTX Black Diamond Therapeutics
$24.61 /

-0.31 (-1.24%)

BDTX Black Diamond Therapeutics
$24.61 /

-0.31 (-1.24%)

Conference/Events
American Association for Cancer Research to hold a virtual meeting » 04:55
04/11/21
04/11
04:55
04/11/21
04:55
MDGEF

MediGene

$4.80 /

+ (+0.00%)

, GLSI

Greenwich LifeSciences

$53.50 /

+4.21 (+8.54%)

, JNCE

Jounce Therapeutics

$9.76 /

-0.65 (-6.24%)

, ATNM

Actinium Pharmaceuticals

$8.10 /

-0.085 (-1.04%)

, BDTX

Black Diamond Therapeutics

$24.61 /

-0.31 (-1.24%)

, CRSP

Crispr Therapeutics

$115.49 /

-4.67 (-3.89%)

, HARP

Harpoon Therapeutics

$22.70 /

-0.03 (-0.13%)

, ITOS

iTeos Therapeutics

$26.99 /

-3.12 (-10.36%)

, REPL

Replimune Group

$30.04 /

-0.52 (-1.70%)

, RVMD

Revolution Medicines

$42.65 /

-2.46 (-5.45%)

, ZNTL

Zentalis

$37.35 /

-5.19 (-12.20%)

, IMCR

Immunocore

$35.01 /

-0.99 (-2.75%)

, PMVP

PMV Pharmaceuticals

$33.30 /

-0.605 (-1.78%)

, ARVN

Arvinas

$63.55 /

-0.83 (-1.29%)

, IOVA

Iovance Biotherapeutics

$30.17 /

-1.12 (-3.58%)

, ADXS

Advaxis

/

+

, AGEN

Agenus

$2.78 /

-0.01 (-0.36%)

, BPTH

Bio-Path

$6.79 /

-0.13 (-1.88%)

, INCY

Incyte

$79.97 /

-0.91 (-1.13%)

, IMAB

I-MAB

$51.50 /

-1.34 (-2.54%)

, MRSN

Mersana Therapeutics

$15.79 /

-0.27 (-1.68%)

, RUBY

Rubius Therapeutics

$23.92 /

-0.14 (-0.58%)

, PPBT

Purple Biotech

$4.31 /

+0.035 (+0.82%)

, SONN

Sonnet BioTherapeutics

$2.24 /

-0.05 (-2.18%)

, STTK

Shattuck Labs

$28.31 /

+1.365 (+5.07%)

, SURF

Surface Oncology

$7.93 /

-0.22 (-2.70%)

, BGNE

BeiGene

$308.27 /

-5.8 (-1.85%)

, CMPI

Checkmate Pharmaceuticals

$10.52 /

+0.14 (+1.35%)

, BNGO

Bionano Genomics

$7.29 /

-0.215 (-2.87%)

AACR Virtual Annual…

AACR Virtual Annual Meeting 2021 will be held on April 9-15. Webcast Link

ShowHide Related Items >><<
ZNTL Zentalis
$37.35 /

-5.19 (-12.20%)

SURF Surface Oncology
$7.93 /

-0.22 (-2.70%)

STTK Shattuck Labs
$28.31 /

+1.365 (+5.07%)

SONN Sonnet BioTherapeutics
$2.24 /

-0.05 (-2.18%)

RVMD Revolution Medicines
$42.65 /

-2.46 (-5.45%)

RUBY Rubius Therapeutics
$23.92 /

-0.14 (-0.58%)

REPL Replimune Group
$30.04 /

-0.52 (-1.70%)

PPBT Purple Biotech
$4.31 /

+0.035 (+0.82%)

PMVP PMV Pharmaceuticals
$33.30 /

-0.605 (-1.78%)

MRSN Mersana Therapeutics
$15.79 /

-0.27 (-1.68%)

JNCE Jounce Therapeutics
$9.76 /

-0.65 (-6.24%)

ITOS iTeos Therapeutics
$26.99 /

-3.12 (-10.36%)

IOVA Iovance Biotherapeutics
$30.17 /

-1.12 (-3.58%)

INCY Incyte
$79.97 /

-0.91 (-1.13%)

IMCR Immunocore
$35.01 /

-0.99 (-2.75%)

IMAB I-MAB
$51.50 /

-1.34 (-2.54%)

HARP Harpoon Therapeutics
$22.70 /

-0.03 (-0.13%)

GLSI Greenwich LifeSciences
$53.50 /

+4.21 (+8.54%)

CRSP Crispr Therapeutics
$115.49 /

-4.67 (-3.89%)

CMPI Checkmate Pharmaceuticals
$10.52 /

+0.14 (+1.35%)

BPTH Bio-Path
$6.79 /

-0.13 (-1.88%)

BNGO Bionano Genomics
$7.29 /

-0.215 (-2.87%)

BGNE BeiGene
$308.27 /

-5.8 (-1.85%)

BDTX Black Diamond Therapeutics
$24.61 /

-0.31 (-1.24%)

ATNM Actinium Pharmaceuticals
$8.10 /

-0.085 (-1.04%)

ARVN Arvinas
$63.55 /

-0.83 (-1.29%)

AGEN Agenus
$2.78 /

-0.01 (-0.36%)

ADXS Advaxis
/

+

MDGEF MediGene
$4.80 /

+ (+0.00%)

GLSI Greenwich LifeSciences
$53.50 /

+4.21 (+8.54%)

JNCE Jounce Therapeutics
$9.76 /

-0.65 (-6.24%)

03/14/21 Piper Sandler
Jounce Therapeutics initiated with an Overweight at Piper Sandler
02/26/21 H.C. Wainwright
Jounce Therapeutics price target raised to $15 from $11 at H.C. Wainwright
12/04/20 H.C. Wainwright
Jounce Therapeutics assumed with a Buy at H.C. Wainwright
11/10/20 Roth Capital
Jounce Therapeutics price target lowered to $15 from $28 at Roth Capital
ATNM Actinium Pharmaceuticals
$8.10 /

-0.085 (-1.04%)

04/06/21 William Blair
Actinium's Q4 net loss roughly in line with projected loss, says William Blair
12/29/20 H.C. Wainwright
H.C. Wainwright keeps Buy on Actinium amid 'headline disappointment'
12/29/20 JonesTrading
Actinium selloff today 'clear buying opportunity,' says JonesTrading
11/05/20
Fly Intel: Top five analyst initiations
BDTX Black Diamond Therapeutics
$24.61 /

-0.31 (-1.24%)

03/29/21 Wedbush
Black Diamond Therapeutics added to Best Ideas List at Wedbush
01/07/21 Wedbush
Wedbush bullish on Black Diamond Therapeutics, initiates with an Outperform
01/06/21 Wedbush
Black Diamond Therapeutics initiated with an Outperform at Wedbush
11/24/20 Berenberg
Black Diamond Therapeutics initiated with a Buy at Berenberg
CRSP Crispr Therapeutics
$115.49 /

-4.67 (-3.89%)

03/17/21 Guggenheim
Editas Medicine assumed with a Neutral at Guggenheim
03/04/21 JMP Securities
Crispr Therapeutics initiated with an Outperform at JMP Securities
03/01/21 Barclays
Crispr Therapeutics price target raised to $140 from $113 at Barclays
02/17/21 Goldman Sachs
Crispr Therapeutics price target lowered to $189 from $193 at Goldman Sachs
HARP Harpoon Therapeutics
$22.70 /

-0.03 (-0.13%)

03/11/21 Roth Capital
Harpoon's 2020/2021 should be 'festival of data,' says Roth Capital
01/04/21 Roth Capital
Harpoon having fourth candidate in clinic 'impressive,' says Roth Capital
12/23/20 H.C. Wainwright
Harpoon Therapeutics assumed with a Buy at H.C. Wainwright
12/16/20 Wedbush
Replimune Group, Harpoon Therapeutics removed from Best Ideas List at Wedbush
ITOS iTeos Therapeutics
$26.99 /

-3.12 (-10.36%)

04/09/21 Piper Sandler
AACR abstracts a 'win' for iTeos Therapeutics, says Piper Sandler
04/05/21 Piper Sandler
Piper Sandler continues to recommend iTeos Therapeutics into data
03/25/21 Wedbush
iTeos Therapeutics price target raised to $52 from $46 at Wedbush
10/07/20 Baird
iTeos Therapeutics initiated with an Outperform at Baird
REPL Replimune Group
$30.04 /

-0.52 (-1.70%)

02/05/21 H.C. Wainwright
Replimune Group price target raised to $60 from $58 at H.C. Wainwright
11/17/20 BTIG
Replimune Group initiated with a Buy at BTIG
11/10/20 H.C. Wainwright
Replimune Group price target raised to $58 from $54 at H.C. Wainwright
RVMD Revolution Medicines
$42.65 /

-2.46 (-5.45%)

03/03/21 SVB Leerink
Revolution Medicines price target raised to $55 from $46 at SVB Leerink
01/29/21 JPMorgan
Revolution Medicines price target raised to $44 from $33 at JPMorgan
10/26/20 H.C. Wainwright
Revolution Medicines price target raised to $54 from $52 at H.C. Wainwright
09/14/20 Jefferies
Inhibrx initiated with a Buy at Jefferies
ZNTL Zentalis
$37.35 /

-5.19 (-12.20%)

03/26/21 H.C. Wainwright
Zentalis price target raised to $65 from $43 at H.C. Wainwright
01/19/21 Wedbush
Zentalis initiated with an Outperform at Wedbush
09/28/20 Cantor Fitzgerald
Cantor starts 'underappreciated' Zentalis with Overweight, $44 target
09/28/20 Cantor Fitzgerald
Zentalis initiated with an Overweight at Cantor Fitzgerald
IMCR Immunocore
$35.01 /

-0.99 (-2.75%)

03/02/21 Jefferies
Immunocore initiated with a Buy at Jefferies
03/02/21 JPMorgan
Immunocore initiated with an Overweight at JPMorgan
03/02/21 Goldman Sachs
Immunocore initiated with a Neutral at Goldman Sachs
PMVP PMV Pharmaceuticals
$33.30 /

-0.605 (-1.78%)

10/20/20 Evercore ISI
PMV Pharmaceuticals initiated with an Outperform at Evercore ISI
10/20/20 BofA
PMV Pharmaceuticals initiated with a Buy at BofA
10/20/20 BofA
PMV Pharmaceuticals initiated with a Buy at BofA
10/20/20 Cowen
PMV Pharmaceuticals initiated with an Outperform at Cowen
ARVN Arvinas
$63.55 /

-0.83 (-1.29%)

03/31/21 BMO Capital
Arvinas initiated with an Outperform at BMO Capital
03/30/21 Cantor Fitzgerald
Arvinas price target raised to $140 from $121 at Cantor Fitzgerald
03/01/21 Roth Capital
Arvinas reaffirmed 'major catalysts' for 2021, says Roth Capital
01/19/21 Oppenheimer
Arvinas price target raised to $100 from $80 at Oppenheimer
IOVA Iovance Biotherapeutics
$30.17 /

-1.12 (-3.58%)

03/08/21 H.C. Wainwright
Iovance Biotherapeutics upgraded to Buy from Neutral at H.C. Wainwright
01/29/21 Baird
Iovance Biotherapeutics assumed at Outperform at Baird
01/14/21 Oppenheimer
Iovance Biotherapeutics price target raised to $57 from $43 at Oppenheimer
12/17/20 Barclays
Iovance Biotherapeutics price target raised to $55 from $43 at Barclays
ADXS Advaxis
/

+

AGEN Agenus
$2.78 /

-0.01 (-0.36%)

09/22/20 B. Riley
B. Riley FBR calls Agenus 'hidden gem' amidst ESMO data releases
09/18/20 Jefferies
Agenus price target raised to $8 from $5 at Jefferies
BPTH Bio-Path
$6.79 /

-0.13 (-1.88%)

04/06/21 H.C. Wainwright
Bio-Path price target raised to $12 from $10 at H.C. Wainwright
04/05/21 Roth Capital
Bio-Path triple regimen data 'highly favorable,' says Roth Capital
03/11/21 Roth Capital
Bio-Path Holdings initiated with a Buy at Roth Capital
11/16/20 H.C. Wainwright
Bio-Path Holdings price target lowered to $10 from $12 at H.C. Wainwright
INCY Incyte
$79.97 /

-0.91 (-1.13%)

02/10/21 SVB Leerink
Incyte downgraded to Market Perform from Outperform at SVB Leerink
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/07/21 Truist
Incyte initiated with a Buy at Truist
01/04/21 Guggenheim
Incyte upgraded to Buy from Neutral at Guggenheim
IMAB I-MAB
$51.50 /

-1.34 (-2.54%)

03/15/21 Needham
I-MAB initiated with a Buy at Needham
03/03/21 H.C. Wainwright
I-MAB price target raised to $75 from $55 at H.C. Wainwright
02/25/21
Fly Intel: Top five analyst initiations
02/25/21 Piper Sandler
I-MAB initiated with an Overweight at Piper Sandler
MRSN Mersana Therapeutics
$15.79 /

-0.27 (-1.68%)

03/30/21 Credit Suisse
Mersana Therapeutics initiated with a Neutral at Credit Suisse
03/30/21 Credit Suisse
Mersana Therapeutics initiated with a Neutral at Credit Suisse
12/02/20 Stifel
Mersana Therapeutics initiated with a Buy at Stifel
09/29/20 JPMorgan
Mersana Therapeutics resumed with a Neutral at JPMorgan
RUBY Rubius Therapeutics
$23.92 /

-0.14 (-0.58%)

03/15/21 H.C. Wainwright
Rubius Therapeutics price target raised to $40 from $28 at H.C. Wainwright
10/14/20 JPMorgan
Rubius Therapeutics resumed with a Neutral at JPMorgan
PPBT Purple Biotech
$4.31 /

+0.035 (+0.82%)

12/31/20 H.C. Wainwright
H.C. Wainwright reiterates Buy, $25 price target on Purple Biotech
SONN Sonnet BioTherapeutics
$2.24 /

-0.05 (-2.18%)

09/04/20 Chardan
Sonnet BioTherapeutics price target raised to $8 from $7 at Chardan
06/05/20 Chardan
Sonnet BioTherapeutics initiated with a Buy at Chardan
STTK Shattuck Labs
$28.31 /

+1.365 (+5.07%)

01/20/21 Citi
Shattuck Labs price target raised to $75 from $36 at Citi
01/11/21 Evercore ISI
Shattuck Labs initiated with an Outperform at Evercore ISI
11/03/20 Needham
Shattuck Labs initiated with a Buy at Needham
11/03/20 Citi
Shattuck Labs initiated with a Buy at Citi
SURF Surface Oncology
$7.93 /

-0.22 (-2.70%)

03/10/21 Wedbush
Surface Oncology risk/reward 'highly favorable' into data, says Wedbush
12/18/20 H.C. Wainwright
Surface Oncology price target raised to $15 from $11 at H.C. Wainwright
09/04/20
Fly Intel: Top five analyst initiations
09/04/20 H.C. Wainwright
Surface Oncology initiated with a Buy at H.C. Wainwright
BGNE BeiGene
$308.27 /

-5.8 (-1.85%)

03/16/21 HSBC
BeiGene price target raised to $385 from $296 at HSBC
03/08/21 China Renaissance
BeiGene initiated with a Buy at China Renaissance
03/04/21 Goldman Sachs
Five Prime acquisition 'a strategic positive' for Amgen, says Goldman Sachs
03/01/21
Fly Intel: Top five analyst downgrades
CMPI Checkmate Pharmaceuticals
$10.52 /

+0.14 (+1.35%)

03/19/21 Jefferies
Checkmate Pharmaceuticals price target lowered to $19 from $23 at Jefferies
09/01/20 Jefferies
Checkmate Pharmaceuticals initiated with a Buy at Jefferies
09/01/20 BofA
BofA starts Checkmate Pharmaceuticals at Neutral ahead of more 'de-risking'
09/01/20 BofA
Checkmate Pharmaceuticals initiated with a Neutral at BofA
BNGO Bionano Genomics
$7.29 /

-0.215 (-2.87%)

02/08/21 Oppenheimer
Bionano Genomics price target raised to $15 from $1.50 at Oppenheimer
01/26/21 Ladenburg
Bionano Genomics price target raised to $14 from $1.25 at Ladenburg
01/22/21 Maxim
Bionano Genomics price target raised to $14 from $2 at Maxim
12/04/20 Roth Capital
Bionano Genomics downgraded to Neutral from Buy at Roth Capital
ZNTL Zentalis
$37.35 /

-5.19 (-12.20%)

SURF Surface Oncology
$7.93 /

-0.22 (-2.70%)

STTK Shattuck Labs
$28.31 /

+1.365 (+5.07%)

RVMD Revolution Medicines
$42.65 /

-2.46 (-5.45%)

RUBY Rubius Therapeutics
$23.92 /

-0.14 (-0.58%)

REPL Replimune Group
$30.04 /

-0.52 (-1.70%)

PMVP PMV Pharmaceuticals
$33.30 /

-0.605 (-1.78%)

MRSN Mersana Therapeutics
$15.79 /

-0.27 (-1.68%)

JNCE Jounce Therapeutics
$9.76 /

-0.65 (-6.24%)

ITOS iTeos Therapeutics
$26.99 /

-3.12 (-10.36%)

IOVA Iovance Biotherapeutics
$30.17 /

-1.12 (-3.58%)

INCY Incyte
$79.97 /

-0.91 (-1.13%)

IMCR Immunocore
$35.01 /

-0.99 (-2.75%)

HARP Harpoon Therapeutics
$22.70 /

-0.03 (-0.13%)

CRSP Crispr Therapeutics
$115.49 /

-4.67 (-3.89%)

CMPI Checkmate Pharmaceuticals
$10.52 /

+0.14 (+1.35%)

BPTH Bio-Path
$6.79 /

-0.13 (-1.88%)

BNGO Bionano Genomics
$7.29 /

-0.215 (-2.87%)

BGNE BeiGene
$308.27 /

-5.8 (-1.85%)

BDTX Black Diamond Therapeutics
$24.61 /

-0.31 (-1.24%)

ARVN Arvinas
$63.55 /

-0.83 (-1.29%)

AGEN Agenus
$2.78 /

-0.01 (-0.36%)

ADXS Advaxis
/

+

  • 17
    Mar
  • 10
    Mar
  • 16
    Feb
  • 09
    Feb
  • 04
    Feb
  • 05
    Feb
  • 20
    Jan
  • 13
    Jan
  • 08
    Jan
  • 07
    Jan
  • 18
    Dec
  • 16
    Dec
  • 02
    Dec
  • 24
    Nov
  • 22
    Oct
  • 09
    Oct
  • 25
    Sep
  • 25
    Sep
  • 07
    Aug
  • 30
    Jul
  • 24
    Jul
  • 09
    Jul
  • 01
    Jul
  • 17
    Jun
  • 09
    Jun
  • 29
    May
  • 29
    May
  • 22
    Apr
INCY Incyte
$79.97 /

-0.91 (-1.13%)

GLSI Greenwich LifeSciences
$53.50 /

+4.21 (+8.54%)

SURF Surface Oncology
$7.93 /

-0.22 (-2.70%)

STTK Shattuck Labs
$28.31 /

+1.365 (+5.07%)

RVMD Revolution Medicines
$42.65 /

-2.46 (-5.45%)

RUBY Rubius Therapeutics
$23.92 /

-0.14 (-0.58%)

REPL Replimune Group
$30.04 /

-0.52 (-1.70%)

MRSN Mersana Therapeutics
$15.79 /

-0.27 (-1.68%)

JNCE Jounce Therapeutics
$9.76 /

-0.65 (-6.24%)

INCY Incyte
$79.97 /

-0.91 (-1.13%)

IMCR Immunocore
$35.01 /

-0.99 (-2.75%)

HARP Harpoon Therapeutics
$22.70 /

-0.03 (-0.13%)

GLSI Greenwich LifeSciences
$53.50 /

+4.21 (+8.54%)

CRSP Crispr Therapeutics
$115.49 /

-4.67 (-3.89%)

BNGO Bionano Genomics
$7.29 /

-0.215 (-2.87%)

ATNM Actinium Pharmaceuticals
$8.10 /

-0.085 (-1.04%)

ARVN Arvinas
$63.55 /

-0.83 (-1.29%)

ZNTL Zentalis
$37.35 /

-5.19 (-12.20%)

RVMD Revolution Medicines
$42.65 /

-2.46 (-5.45%)

REPL Replimune Group
$30.04 /

-0.52 (-1.70%)

PPBT Purple Biotech
$4.31 /

+0.035 (+0.82%)

PMVP PMV Pharmaceuticals
$33.30 /

-0.605 (-1.78%)

INCY Incyte
$79.97 /

-0.91 (-1.13%)

CRSP Crispr Therapeutics
$115.49 /

-4.67 (-3.89%)

BNGO Bionano Genomics
$7.29 /

-0.215 (-2.87%)

BDTX Black Diamond Therapeutics
$24.61 /

-0.31 (-1.24%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.